Pathways of Protein Secretion in Prokaryotes and Eukaryotes: Molecular Mechanisms, Biological Functions, and Therapeutic Opportunities

Abstract

Protein secretion is a fundamental biological process essential for cellular communication, matrix remodeling, and overall homeostasis across all domains of life. While the classical endoplasmic reticulum (ER)-to-Golgi pathway has long been recognized as the primary route for eukaryotic protein export, decades of research reveal that numerous cytosolic and membrane proteins bypass this canonical route. This alternative paradigm, termed unconventional protein secretion (UcPS), encompasses direct transmembrane translocation, vesicle-mediated release, and Golgi-bypass mechanisms. Simultaneously, prokaryotes utilize highly specialized secretion machineries to deliver effector proteins. Despite these established frameworks, the precise molecular regulation, cargo sorting mechanisms, and dynamic crosstalk between these diverse pathways remain incompletely understood. Here, we comprehensively review the molecular mechanisms of UcPS and prokaryotic secretion systems, synthesizing their evolutionary adaptations and operational frameworks. By mapping nonvesicular pores, extracellular vesicles intermediates, and complex bacterial nanomachine assemblies, we delineate how cells rapidly mobilize proteins under stress. Furthermore, we highlight the dual role of these pathways in driving physiological adaptation versus fueling pathological dissemination. Abnormalities in these secretory nodes are now recognized as primary drivers of neurodegeneration, inflammatory disorders, and cancer metastasis. Consequently, manipulating UcPS mechanisms offers promising, multidimensional therapeutic opportunities for future medicine.

Keywords

bacterial secretion systems / extracellular vesicles / Golgi bypass / secretory autophagy / targeted therapy / unconventional protein secretion (UcPS)

References

[1] G. Palade, “Intracellular Aspects of the Process of Protein Synthesis,” Science 189, no. 4200 (1975): 347–358.

[2] N. Dupont, S. Jiang, M. Pilli, W. Ornatowski, D. Bhattacharya, and V. Deretic, “Autophagy-Based Unconventional Secretory Pathway for Extracellular Delivery of Il-1β,” Embo Journal 30, no. 23 (2011): 4701–4711.

[3] H. Y. Gee, S. H. Noh, B. L. Tang, K. H. Kim, and M. G. Lee, “Rescue of Δf508-Cftr Trafficking via a Grasp-Dependent Unconventional Secretion Pathway,” Cell 146, no. 5 (2011): 746–760.

[4] M. Zeitler, J. P. Steringer, H. M. Müller, M. P. Mayer, and W. Nickel, “Hiv-Tat Protein Forms Phosphoinositide-Dependent Membrane Pores Implicated in Unconventional Protein Secretion,” Journal of Biological Chemistry 290, no. 36 (2015): 21976–21984.

[5] C. Rabouille, V. Malhotra, and W. Nickel, “Diversity in Unconventional Protein Secretion,” Journal of Cell Science 125, no. 22 (2012): 5251–5255.

[6] A. Filloux, “Bacterial Protein Secretion Systems: Game of Types,” Microbiology 168, no. 5 (2022): 10.1099/mic.0.001193.

[7] D. Jiang, J. He, and L. Yu, “The Migrasome, an Organelle for Cell–Cell Communication,” Trends in Cell Biology 35, no. 3 (2025): 205–216.

[8] J. Beckwith, “The Sec-Dependent Pathway,” Research in Microbiology 164, no. 6 (2013): 497–504.

[9] X. Zhang, R. Rashid, K. Wang, and S. O. Shan, “Sequential Checkpoints Govern Substrate Selection during Cotranslational Protein Targeting,” Science 328, no. 5979 (2010): 757–760.

[10] I. Saraogi, D. Akopian, and S. O. Shan, “Regulation of Cargo Recognition, Commitment, and Unloading Drives Cotranslational Protein Targeting,” Journal of Cell Biology 205, no. 5 (2014): 693–706.

[11] G. Orfanoudaki and A. Economou, “Proteome-Wide Subcellular Topologies of E. Coli Polypeptides Database (Stepdb),” Molecular & Cellular Proteomics 13, no. 12 (2014): 3674–3687.

[12] D. Huber, N. Rajagopalan, S. Preissler, et al., “Seca Interacts with Ribosomes in Order to Facilitate Posttranslational Translocation in Bacteria,” Molecular Cell 41, no. 3 (2011): 343–353.

[13] F. Merz, D. Boehringer, C. Schaffitzel, et al., “Molecular Mechanism and Structure of Trigger Factor Bound to the Translating Ribosome,” Embo Journal 27, no. 11 (2008): 1622–1632.

[14] A. Hoffmann, B. Bukau, and G. Kramer, “Structure and Function of the Molecular Chaperone Trigger Factor,” Biochimica Et Biophysica Acta 1803, no. 6 (2010): 650–661.

[15] A. Sala, P. Bordes, and P. Genevaux, “Multitasking Secb Chaperones in Bacteria,” Frontiers in Microbiology 5 (2014): 666.

[16] M. P. Castanié-Cornet, N. Bruel, and P. Genevaux, “Chaperone Networking Facilitates Protein Targeting to the Bacterial Cytoplasmic Membrane,” Biochimica Et Biophysica Acta 1843, no. 8 (2014): 1442–1456.

[17] T. Saio, X. Guan, P. Rossi, A. Economou, and C. G. Kalodimos, “Structural Basis for Protein Antiaggregation Activity of the Trigger Factor Chaperone,” Science 344, no. 6184 (2014): 1250494.

[18] K. E. Chatzi, M. F. Sardis, A. Economou, and S. Karamanou, “Seca-Mediated Targeting and Translocation of Secretory Proteins,” Biochimica Et Biophysica Acta 1843, no. 8 (2014): 1466–1474.

[19] F. U. Hartl, S. Lecker, E. Schiebel, J. P. Hendrick, and W. Wickner, “The Binding Cascade of Secb to Seca to Secy/E Mediates Preprotein Targeting to the E. Coli Plasma Membrane,” Cell 63, no. 2 (1990): 269–279.

[20] L. Brundage, J. P. Hendrick, E. Schiebel, A. J. Driessen, and W. Wickner, “The Purified E. Coli Integral Membrane Protein Secy/E Is Sufficient for Reconstitution of Seca-Dependent Precursor Protein Translocation,” Cell 62, no. 4 (1990): 649–657.

[21] G. Gouridis, S. Karamanou, I. Gelis, C. G. Kalodimos, and A. Economou, “Signal Peptides Are Allosteric Activators of the Protein Translocase,” Nature 462, no. 7271 (2009): 363–367.

[22] I. Gelis, A. M. Bonvin, D. Keramisanou, et al., “Structural Basis for Signal-Sequence Recognition by the Translocase Motor Seca as Determined by Nmr,” Cell 131, no. 4 (2007): 756–769.

[23] G. Gouridis, S. Karamanou, M. F. Sardis, M. A. Schärer, G. Capitani, and A. Economou, “Quaternary Dynamics of the Seca Motor Drive Translocase Catalysis,” Molecular Cell 52, no. 5 (2013): 655–666.

[24] I. Taufik, A. Kedrov, M. Exterkate, and A. J. Driessen, “Monitoring the Activity of Single Translocons,” Journal of Molecular Biology 425, no. 22 (2013): 4145–4153.

[25] A. Economou and W. Wickner, “Seca Promotes Preprotein Translocation by Undergoing Atp-Driven Cycles of Membrane Insertion and Deinsertion,” Cell 78, no. 5 (1994): 835–843.

[26] J. Zimmer, Y. Nam, and T. A. Rapoport, “Structure of a Complex of the Atpase Seca and the Protein-Translocation Channel,” Nature 455, no. 7215 (2008): 936–943.

[27] B. W. Bauer, T. Shemesh, Y. Chen, and T. A. Rapoport, “A “Push and Slide” Mechanism Allows Sequence-Insensitive Translocation of Secretory Proteins by the Seca Atpase,” Cell 157, no. 6 (2014): 1416–1429.

[28] K. J. Erlandson, S. B. Miller, Y. Nam, A. R. Osborne, J. Zimmer, and T. A. Rapoport, “A Role for the Two-Helix Finger of the Seca Atpase in Protein Translocation,” Nature 455, no. 7215 (2008): 984–987.

[29] E. Schiebel, A. J. Driessen, F. U. Hartl, and W. Wickner, “Delta Mu H+ and Atp Function at Different Steps of the Catalytic Cycle of Preprotein Translocase,” Cell 64, no. 5 (1991): 927–939.

[30] R. Lill, W. Dowhan, and W. Wickner, “The Atpase Activity of Seca Is Regulated by Acidic Phospholipids, Secy, and the Leader and Mature Domains of Precursor Proteins,” Cell 60, no. 2 (1990): 271–280.

[31] S. Karamanou, G. Gouridis, E. Papanikou, et al., “Preprotein-Controlled Catalysis in the Helicase Motor of Seca,” Embo Journal 26, no. 12 (2007): 2904–2914.

[32] B. Van den Berg, W. M. Clemons,, I. Collinson, et al., “X-Ray Structure of a Protein-Conducting Channel,” Nature 427, no. 6969 (2004): 36–44.

[33] L. Li, E. Park, J. Ling, J. Ingram, H. Ploegh, and T. A. Rapoport, “Crystal Structure of a Substrate-Engaged Secy Protein-Translocation Channel,” Nature 531, no. 7594 (2016): 395–399.

[34] S. M. Saparov, K. Erlandson, K. Cannon, et al., “Determining the Conductance of the Secy Protein Translocation Channel for Small Molecules,” Molecular Cell 26, no. 4 (2007): 501–509.

[35] A. Tsirigotaki, J. De Geyter, N. Šoštaric´, A. Economou, and S. Karamanou, “Protein Export through the Bacterial Sec Pathway,” Nature Reviews Microbiology 15, no. 1 (2016): 21–36.

[36] S. M. Auclair, M. K. Bhanu, and D. A. Kendall, “Signal Peptidase I: Cleaving the Way to Mature Proteins,” Protein Science 21, no. 1 (2012): 13–25.

[37] R. Antonoaea, M. Fürst, K. Nishiyama, and M. Müller, “The Periplasmic Chaperone Ppid Interacts with Secretory Proteins Exiting from the Secyeg Translocon,” Biochemistry 47, no. 20 (2008): 5649–5656.

[38] P. Walter, I. Ibrahimi, and G. Blobel, “Translocation of Proteins across the Endoplasmic Reticulum. I. Signal Recognition Protein (Srp) Binds to in-Vitro-Assembled Polysomes Synthesizing Secretory Protein,” Journal of Cell Biology 91, no. 2 Pt 1 (1981): 545–550.

[39] D. T. Ng, J. D. Brown, and P. Walter, “Signal Sequences Specify the Targeting Route to the Endoplasmic Reticulum Membrane,” Journal of Cell Biology 134, no. 2 (1996): 269–278.

[40] C. Carrie, S. Weißenberger, and J. Soll, “Plant Mitochondria Contain the Protein Translocase Subunits Tatb and Tatc,” Journal of Cell Science 129, no. 20 (2016): 3935–3947.

[41] M. Petrů, J. Wideman, K. Moore, F. Alcock, T. Palmer, and P. Doležal, “Evolution of Mitochondrial Tat Translocases Illustrates the Loss of Bacterial Protein Transport Machines in Mitochondria,” BMC Biology 16, no. 1 (2018): 141.

[42] W. Pett and D. V. Lavrov, “The Twin-Arginine Subunit C in Oscarella: Origin, Evolution, and Potential Functional Significance,” Integrative and Comparative Biology 53, no. 3 (2013): 495–502.

[43] A. M. Settles, A. Yonetani, A. Baron, D. R. Bush, K. Cline, and R. Martienssen, “Sec-Independent Protein Translocation by the Maize Hcf106 Protein,” Science 278, no. 5342 (1997): 1467–1470.

[44] B. C. Berks, “The Twin-Arginine Protein Translocation Pathway,” Annual Review of Biochemistry 84 (2015): 843–864.

[45] S. Hamsanathan and S. M. Musser, “The Tat Protein Transport System: Intriguing Questions and Conundrums,” Fems Microbiology Letters 365, no. 12 (2018): fny23.

[46] P. Rose, J. Fröbel, P. L. Graumann, and M. Müller, “Substrate-Dependent Assembly of the Tat Translocase as Observed in Live Escherichia Coli Cells,” PLoS One 8, no. 8 (2013): e69488.

[47] H. Mori and K. Cline, “A Twin Arginine Signal Peptide and the Ph Gradient Trigger Reversible Assembly of the Thylakoid [Delta]Ph/Tat Translocase,” Journal of Cell Biology 157, no. 2 (2002): 205–210.

[48] F. Alcock, M. A. Baker, N. P. Greene, T. Palmer, M. I. Wallace, and B. C. Berks, “Live Cell Imaging Shows Reversible Assembly of the Tata Component of the Twin-Arginine Protein Transport System,” Proceedings of the National Academy of Sciences of the United States of America 110, no. 38 (2013): E3650–E3659.

[49] M. Alami, I. Lüke, S. Deitermann, et al., “Differential Interactions between a Twin-Arginine Signal Peptide and Its Translocase in Escherichia Coli,” Molecular Cell 12, no. 4 (2003): 937–946.

[50] J. Habersetzer, K. Moore, J. Cherry, G. Buchanan, P. J. Stansfeld, and T. Palmer, “Substrate-Triggered Position Switching of Tata and Tatb during Tat Transport in Escherichia Coli,” Open Biology 7, no. 8 (2017): 170091.

[51] A. Bolhuis, J. E. Mathers, J. D. Thomas, C. M. Barrett, and C. Robinson, “Tatb and Tatc Form a Functional and Structural Unit of the Twin-Arginine Translocase from Escherichia Coli,” Journal of Biological Chemistry 276, no. 23 (2001): 20213–20219.

[52] F. Alcock, P. J. Stansfeld, H. Basit, et al., “Assembling the Tat Protein Translocase,” Elife 5 (2016): e20718.

[53] S. E. Rollauer, M. J. Tarry, J. E. Graham, et al., “Structure of the Tatc Core of the Twin-Arginine Protein Transport System,” Nature 492, no. 7428 (2012): 210–214.

[54] A. S. Blümmel, L. A. Haag, E. Eimer, M. Müller, and J. Fröbel, “Initial Assembly Steps of a Translocase for Folded Proteins,” Nature Communications 6 (2015): 7234.

[55] S. Hamsanathan, T. S. Anthonymuthu, U. K. Bageshwar, and S. M. Musser, “A Hinged Signal Peptide Hairpin Enables Tat-Dependent Protein Translocation,” Biophysical Journal 113, no. 12 (2017): 2650–2668.

[56] F. Gérard and K. Cline, “The Thylakoid Proton Gradient Promotes an Advanced Stage of Signal Peptide Binding Deep within the Tat Pathway Receptor Complex,” Journal of Biological Chemistry 282, no. 8 (2007): 5263–5272.

[57] T. Brüser and C. Sanders, “An Alternative Model of the Twin Arginine Translocation System,” Microbiological Research 158, no. 1 (2003): 7–17.

[58] U. Gohlke, L. Pullan, C. A. McDevitt, et al., “The Tata Component of the Twin-Arginine Protein Transport System Forms Channel Complexes of Variable Diameter,” Proceedings of the National Academy of Sciences of the United States of America 102, no. 30 (2005): 10482–10486.

[59] M. C. Leake, N. P. Greene, R. M. Godun, et al., “Variable Stoichiometry of the Tata Component of the Twin-Arginine Protein Transport System Observed by in Vivo Single-Molecule Imaging,” Proceedings of the National Academy of Sciences of the United States of America 105, no. 40 (2008): 15376–15381.

[60] F. Rodriguez, S. L. Rouse, C. E. Tait, et al., “Structural Model for the Protein-Translocating Element of the Twin-Arginine Transport System,” Proceedings of the National Academy of Sciences of the United States of America 110, no. 12 (2013): E1092–E1101.

[61] Q. Huang and T. Palmer, “Signal Peptide Hydrophobicity Modulates Interaction with the Twin-Arginine Translocase,” MBio 8, no. 4 (2017): e00909-17.

[62] D. Tullman-Ercek, M. P. DeLisa, Y. Kawarasaki, et al., “Export Pathway Selectivity of Escherichia Coli Twin Arginine Translocation Signal Peptides,” Journal of Biological Chemistry 282, no. 11 (2007): 8309–8316.

[63] S. Cristóbal, J. W. de Gier, H. Nielsen, and G. von Heijne, “Competition between Sec- and Tat-Dependent Protein Translocation in Escherichia Coli,” Embo Journal 18, no. 11 (1999): 2982–2990.

[64] E. Bogsch, S. Brink, and C. Robinson, “Pathway Specificity for a Delta Ph-Dependent Precursor Thylakoid Lumen Protein Is Governed by a ‘Sec-Avoidance’ Motif in the Transfer Peptide and a ‘Sec-Incompatible’ Mature Protein,” Embo Journal 16, no. 13 (1997): 3851–3859.

[65] N. Blaudeck, G. A. Sprenger, R. Freudl, and T. Wiegert, “Specificity of Signal Peptide Recognition in Tat-Dependent Bacterial Protein Translocation,” Journal of Bacteriology 183, no. 2 (2001): 604–610.

[66] N. R. Stanley, T. Palmer, and B. C. Berks, “The Twin Arginine Consensus Motif of Tat Signal Peptides Is Involved in Sec-Independent Protein Targeting in Escherichia Coli,” Journal of Biological Chemistry 275, no. 16 (2000): 11591–11596.

[67] R. Keller, J. de Keyzer, A. J. Driessen, and T. Palmer, “Co-Operation between Different Targeting Pathways during Integration of a Membrane Protein,” Journal of Cell Biology 199, no. 2 (2012): 303–315.

[68] B. C. Berks, F. Sargent, and T. Palmer, “The Tat Protein Export Pathway,” Molecular Microbiology 35, no. 2 (2000): 260–274.

[69] B. C. Berks, “A Common Export Pathway for Proteins Binding Complex Redox Cofactors?” Molecular Microbiology 22, no. 3 (1996): 393–404.

[70] F. J. Tooke, M. Babot, G. Chandra, G. Buchanan, and T. Palmer, “A Unifying Mechanism for the Biogenesis of Membrane Proteins Co-Operatively Integrated by the Sec and Tat Pathways,” Elife 6 (2017): e26577.

[71] M. Dean, Y. Hamon, and G. Chimini, “The Human Atp-Binding Cassette (Abc) Transporter Superfamily,” Journal of Lipid Research 42, no. 7 (2001): 1007–1017.

[72] A. Alam and K. P. Locher, “Structure and Mechanism of Human Abc Transporters,” Annual Review of Biophysics 52 (2023): 275–300.

[73] E. Schneider and S. Hunke, “Atp-Binding-Cassette (Abc) Transport Systems: Functional and Structural Aspects of the Atp-Hydrolyzing Subunits/Domains,” Fems Microbiology Review 22, no. 1 (1998): 1–20.

[74] J. P. McGrath and A. Varshavsky, “The Yeast Ste6 Gene Encodes a Homologue of the Mammalian Multidrug Resistance P-Glycoprotein,” Nature 340, no. 6232 (1989): 400–404.

[75] P. U. Christensen, J. Davey, and O. Nielsen, “The Schizosaccharomyces Pombe Mam1 Gene Encodes an Abc Transporter Mediating Secretion of M-Factor,” Molecular and General Genetics MGG 255, no. 2 (1997): 226–236.

[76] D. G. Russell, P. W. Denny, S. Gokool, M. C. Field, and D. F. Smith, “Acylation-Dependent Protein Export in<Em>Leishmania</Em>*,” Journal of Biological Chemistry 275, no. 15 (2000): 11017–11025.

[77] L. M. MacLean, P. J. O'Toole, M. Stark, et al., “Trafficking and Release of Leishmania Metacyclic Haspb on Macrophage Invasion,” Cellular Microbiology 14, no. 5 (2012): 740–761.

[78] A. Joliot, “Role of Pi(4,5)P2 and Cholesterol in Unconventional Protein Secretion,” Advances in Experimental Medicine and Biology 1422 (2023): 381–392.

[79] C. Rabouille, “Pathways of Unconventional Protein Secretion,” Trends in Cell Biology 27, no. 3 (2017): 230–240.

[80] F. Lolicato, J. P. Steringer, R. Saleppico, et al., “Disulfide Bridge-Dependent Dimerization Triggers Fgf2 Membrane Translocation into the Extracellular Space,” Elife 12 (2024): RP88579.

[81] M. R. Akl, P. Nagpal, N. M. Ayoub, et al., “Molecular and Clinical Significance of Fibroblast Growth Factor 2 (Fgf2 /Bfgf) in Malignancies of Solid and Hematological Cancers for Personalized Therapies,” Oncotarget 7, no. 28 (2016): 44735–44762.

[82] E. Dimou, K. Cosentino, E. Platonova, et al., “Single Event Visualization of Unconventional Secretion of Fgf2,” Journal of Cell Biology 218, no. 2 (2019): 683–699.

[83] C. Legrand, R. Saleppico, J. Sticht, et al., “The Na,K-Atpase Acts Upstream of Phosphoinositide Pi(4,5)P(2) Facilitating Unconventional Secretion of Fibroblast Growth Factor 2,” Communications Biology 3, no. 1 (2020): 141.

[84] J. P. Steringer, S. Lange, S. Čujová, et al., “Key Steps in Unconventional Secretion of Fibroblast Growth Factor 2 Reconstituted with Purified Components,” Elife 6 (2017): e28985.

[85] J. P. Steringer, H. M. Müller, and W. Nickel, “Unconventional Secretion of Fibroblast Growth Factor 2–a Novel Type of Protein Translocation across Membranes?” Journal of Molecular Biology 427, no. 6 Pt A (2015): 1202–1210.

[86] H. Wang, M. Zhang, and L. Ge, “Cholesterol: Enhancing Fgf2 Translocation in Unconventional Secretion,” Journal of Cell Biology 221, no. 11 (2022): e202210007.

[87] G. La Venuta, S. Wegehingel, P. Sehr, et al., “Small Molecule Inhibitors Targeting Tec Kinase Block Unconventional Secretion of Fibroblast Growth Factor 2,” Journal of Biological Chemistry 291, no. 34 (2016): 17787–17803.

[88] T. Schäfer, H. Zentgraf, C. Zehe, B. Brügger, J. Bernhagen, and W. Nickel, “Unconventional Secretion of Fibroblast Growth Factor 2 Is Mediated by Direct Translocation across the Plasma Membrane of Mammalian Cells,” Journal of Biological Chemistry 279, no. 8 (2004): 6244–6251.

[89] W. Nickel, “Unconventional Secretion: An Extracellular Trap for Export of Fibroblast Growth Factor 2,” Journal of Cell Science 120, no. Pt 14 (2007): 2295–2299.

[90] M. A. Nugent and R. V. Iozzo, “Fibroblast Growth Factor-2,” International Journal of Biochemistry & Cell Biology 32, no. 2 (2000): 115–120.

[91] J. Schlessinger, A. N. Plotnikov, O. A. Ibrahimi, et al., “Crystal Structure of a Ternary Fgf-Fgfr-Heparin Complex Reveals a Dual Role for Heparin in Fgfr Binding and Dimerization,” Molecular Cell 6, no. 3 (2000): 743–750.

[92] C. Zehe, A. Engling, S. Wegehingel, T. Schäfer, and W. Nickel, “Cell-Surface Heparan Sulfate Proteoglycans Are Essential Components of the Unconventional Export Machinery of Fgf-2,” Proceedings of the National Academy of Sciences of the United States of America 103, no. 42 (2006): 15479–15484.

[93] F. Rayne, S. Debaisieux, A. Bonhoure, and B. Beaumelle, “Hiv-1 Tat Is Unconventionally Secreted through the Plasma Membrane,” Cell Biology International 34, no. 4 (2010): 409–413.

[94] I. S. Afonina, C. Müller, S. J. Martin, and R. Beyaert, “Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme,” Immunity 42, no. 6 (2015): 991–1004.

[95] O. Takeuchi and S. Akira, “Pattern Recognition Receptors and Inflammation,” Cell 140, no. 6 (2010): 805–820.

[96] D. Brough and N. J. Rothwell, “Caspase-1-Dependent Processing of Pro-Interleukin-1beta Is Cytosolic and Precedes Cell Death,” Journal of Cell Science 120, no. Pt 5 (2007): 772–781.

[97] G. Lopez-Castejon and D. Brough, “Understanding the Mechanism of Il-1β Secretion,” Cytokine & Growth Factor Reviews 22, no. 4 (2011): 189–195.

[98] Y. I. Huang, W. Xu, and R. Zhou, “Nlrp3 Inflammasome Activation and Cell Death,” Cellular & Molecular Immunology 18, no. 9 (2021): 2114–2127.

[99] T. Bergsbaken, S. L. Fink, and B. T. Cookson, “Pyroptosis: Host Cell Death and Inflammation,” Nature Reviews Microbiology 7, no. 2 (2009): 99–109.

[100] F. Martín-Sánchez, C. Diamond, M. Zeitler, et al., “Inflammasome-Dependent Il-1β Release Depends Upon Membrane Permeabilisation,” Cell Death & Differentiation 23, no. 7 (2016): 1219–1231.

[101] N. Kayagaki, I. B. Stowe, B. L. Lee, et al., “Caspase-11 Cleaves Gasdermin D for Non-Canonical Inflammasome Signalling,” Nature 526, no. 7575 (2015): 666–671.

[102] J. Shi, Y. Zhao, K. Wang, et al., “Cleavage of Gsdmd by Inflammatory Caspases Determines Pyroptotic Cell Death,” Nature 526, no. 7575 (2015): 660–665.

[103] Z. Liu, C. Wang, J. K. Rathkey, et al., “Structures of the Gasdermin D C-Terminal Domains Reveal Mechanisms of Autoinhibition,” Structure 26, no. 5 (2018): 778–784.e3.

[104] X. Liu, Z. Zhang, J. Ruan, et al., “Inflammasome-Activated Gasdermin D Causes Pyroptosis by Forming Membrane Pores,” Nature 535, no. 7610 (2016): 153–158.

[105] K. W. Chen, M. Monteleone, D. Boucher, et al., “Noncanonical Inflammasome Signaling Elicits Gasdermin D-Dependent Neutrophil Extracellular Traps,” Science Immunology 3, no. 26 (2018): eaar6676.

[106] B. E. Burdette, A. N. Esparza, H. Zhu, and S. Wang, “Gasdermin D in Pyroptosis,” Acta Pharmaceutica Sinica B 11, no. 9 (2021): 2768–2782.

[107] I. Zanoni, Y. Tan, M. Di Gioia, et al., “An Endogenous Caspase-11 Ligand Elicits Interleukin-1 Release from Living Dendritic Cells,” Science 352, no. 6290 (2016): 1232–1236.

[108] C. L. Evavold, J. Ruan, Y. Tan, S. Xia, H. Wu, and J. C. Kagan, “The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages,” Immunity 48, no. 1 (2018): 35–44.e6.

[109] S. Rühl, K. Shkarina, B. Demarco, R. Heilig, J. C. Santos, and P. Broz, “Escrt-Dependent Membrane Repair Negatively Regulates Pyroptosis Downstream of Gsdmd Activation,” Science 362, no. 6417 (2018): 956–960.

[110] R. Heilig, M. S. Dick, L. Sborgi, E. Meunier, S. Hiller, and P. Broz, “The Gasdermin-D Pore Acts as a Conduit for Il-1β Secretion in Mice,” European Journal of Immunology 48, no. 4 (2018): 584–592.

[111] D. Ferrari, M. Villalba, P. Chiozzi, S. Falzoni, P. Ricciardi-Castagnoli, and F. Di Virgilio, “Mouse Microglial Cells Express a Plasma Membrane Pore Gated by Extracellular Atp,” Journal of Immunology 156, no. 4 (1996): 1531–1539.

[112] D. Ferrari, P. Chiozzi, S. Falzoni, et al., “Extracellular Atp Triggers Il-1 Beta Release by Activating the Purinergic P2z Receptor of Human Macrophages,” Journal of Immunology 159, no. 3 (1997): 1451–1458.

[113] M. Adamczyk, R. Griffiths, S. Dewitt, V. Knäuper, and D. Aeschlimann, “P2X7 Receptor Activation Regulates Rapid Unconventional Export of Transglutaminase-2,” Journal of Cell Science 128, no. 24 (2015): 4615–4628.

[114] D. G. Perregaux and C. A. Gabel, “Human Monocyte Stimulus-Coupled Il-1β Posttranslational Processing:: Modulation via Monovalent Cations,” American Journal of Physiology-Cell Physiology 275, no. 6 (1998): C1538–C1547.

[115] D. G. Perregaux, P. McNiff, R. Laliberte, M. Conklyn, and C. A. Gabel, “Atp Acts as an Agonist to Promote Stimulus-Induced Secretion of Il-1 Beta and Il-18 in Human Blood,” Journal of Immunology 165, no. 8 (2000): 4615–4623.

[116] D. Ferrari, C. Pizzirani, E. Adinolfi, et al., “The P2X7 Receptor: A Key Player in Il-1 Processing and Release1,” The Journal of Immunology 176, no. 7 (2006): 3877–3883.

[117] F. Di Virgilio, D. D. Ben, A. C. Sarti, A. L. Giuliani, and S. Falzoni, “The P2X7 Receptor in Infection and Inflammation,” Immunity 47, no. 1 (2017): 15–31.

[118] J. Bockstiegel, J. Engelhardt, and G. Weindl, “P2X7 Receptor Activation Leads to Nlrp3-Independent Il-1β Release by Human Macrophages,” Cell Communication and Signaling 21, no. 1 (2023): 335.

[119] S. Mitra and A. Sarkar, “Microparticulate P2X7 and Gsdm-D Mediated Regulation of Functional Il-1β Release,” Purinergic Signalling 15, no. 1 (2018): 119–123.

[120] K. A. Hogquist, M. A. Nett, E. R. Unanue, and D. D. Chaplin, “Interleukin 1 Is Processed and Released during Apoptosis,” Proceedings of the National Academy of Sciences of the United States of America 88, no. 19 (1991): 8485–8489.

[121] D. Perregaux, J. Barberia, A. J. Lanzetti, K. F. Geoghegan, T. J. Carty, and C. A. Gabel, “Il-1 Beta Maturation: Evidence That Mature Cytokine Formation Can Be Induced Specifically by Nigericin,” Journal of Immunology 149, no. 4 (1992): 1294–1303.

[122] G. Fantuzzi, G. Ku, M. W. Harding, et al., “Response to Local Inflammation of Il-1 Beta-Converting Enzyme- Deficient Mice,” Journal of Immunology 158, no. 4 (1997): 1818–1824.

[123] C. Stehlik, “Multiple Interleukin-1beta-Converting Enzymes Contribute to Inflammatory Arthritis,” Arthritis and Rheumatism 60, no. 12 (2009): 3524–3530.

[124] A. MacKenzie, H. L. Wilson, E. Kiss-Toth, S. K. Dower, R. A. North, and A. Surprenant, “Rapid Secretion of Interleukin-1beta by Microvesicle Shedding,” Immunity 15, no. 5 (2001): 825–835.

[125] J. Harris, M. Hartman, C. Roche, et al., “Autophagy Controls Il-1beta Secretion by Targeting Pro-Il-1beta for Degradation,” Journal of Biological Chemistry 286, no. 11 (2011): 9587–9597.

[126] C. Pizzirani, D. Ferrari, P. Chiozzi, et al., “Stimulation of P2 Receptors Causes Release of Il-1beta-Loaded Microvesicles from Human Dendritic Cells,” Blood 109, no. 9 (2007): 3856–3864.

[127] S. L. Fink and B. T. Cookson, “Caspase-1-Dependent Pore Formation during Pyroptosis Leads to Osmotic Lysis of Infected Host Macrophages,” Cellular Microbiology 8, no. 11 (2006): 1812–1825.

[128] S. Zacherl, G. La Venuta, H. M. Müller, et al., “A Direct Role for Atp1a1 in Unconventional Secretion of Fibroblast Growth Factor 2,” Journal of Biological Chemistry 290, no. 6 (2015): 3654–3665.

[129] S. Qian, W. Wang, L. Yang, and H. W. Huang, “Structure of Transmembrane Pore Induced by Bax-Derived Peptide: Evidence for Lipidic Pores,” Proceedings of the National Academy of Sciences of the United States of America 105, no. 45 (2008): 17379–17383.

[130] Y. He, H. Hara, and G. Núñez, “Mechanism and Regulation of Nlrp3 Inflammasome Activation,” Trends in Biochemical Sciences 41, no. 12 (2016): 1012–1021.

[131] S. Ruben, A. Perkins, R. Purcell, et al., “Structural and Functional Characterization of Human Immunodeficiency Virus Tat Protein,” Journal of Virology 63, no. 1 (1989): 1–8.

[132] J. H. Kaplan, “Biochemistry of Na,K-Atpase,” Annual Review of Biochemistry 71 (2002): 511–535.

[133] S. Agostini, H. Ali, C. Vardabasso, et al., “Inhibition of Non Canonical Hiv-1 Tat Secretion through the Cellular Na(+),K(+)-Atpase Blocks Hiv-1 Infection,” eBioMedicine 21 (2017): 170–181.

[134] M. Zhang, L. Liu, X. Lin, et al., “A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion,” Cell 181, no. 3 (2020): 637–652.e15.

[135] M. Landriscina, R. Soldi, C. Bagalá, et al., “S100a13 Participates in the Release of Fibroblast Growth Factor 1 in Response to Heat Shock in Vitro,” Journal of Biological Chemistry 276, no. 25 (2001): 22544–22552.

[136] P. T. Gotora, R. van der Sluis, and M. E. Williams, “Hiv-1 Tat Amino Acid Residues That Influence Tat-Tar Binding Affinity: A Scoping Review,” BMC Infectious Diseases [Electronic Resource] 23, no. 1 (2023): 164.

[137] K. Yokota, K. Sato, T. Miyazaki, et al., “Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis,” Arthritis & Rheumatology 73, no. 7 (2021): 1145–1154.

[138] N. Li, J. X. Wang, T. T. Huo, J. R. Zhao, and T. J. Wang, “Associations of Il-1β and Il-6 Gene Polymorphisms with Parkinson's Disease,” European Review for Medical and Pharmacological Sciences 25, no. 2 (2021): 890–897.

[139] T. Kiyota, K. L. Ingraham, M. T. Jacobsen, H. Xiong, and T. Ikezu, “Fgf2 Gene Transfer Restores Hippocampal Functions in Mouse Models of Alzheimer's Disease and Has Therapeutic Implications for Neurocognitive Disorders,” Proceedings of the National Academy of Sciences of the United States of America 108, no. 49 (2011): E1339–e1348.

[140] J. A. Fields, W. Dumaop, L. Crews, et al., “Mechanisms of Hiv-1 Tat Neurotoxicity via Cdk5 Translocation and Hyper-Activation: Role in Hiv-Associated Neurocognitive Disorders,” Current HIV Research 13, no. 1 (2015): 43–54.

[141] P. E. Ray, J. Li, J. R. Das, and P. Tang, “Childhood Hiv-Associated Nephropathy: 36 Years Later,” Pediatric Nephrology 36, no. 8 (2021): 2189–2201.

[142] Y. Jiang, L. Chai, M. B. Fasae, and Y. Bai, “The Role of Hiv Tat Protein in Hiv-Related Cardiovascular Diseases,” Journal of Translational Medicine 16, no. 1 (2018): 121.

[143] L. Langemeyer, F. Fröhlich, and C. Ungermann, “Rab Gtpase Function in Endosome and Lysosome Biogenesis,” Trends in Cell Biology 28, no. 11 (2018): 957–970.

[144] M. Remec Pavlin and J. H. Hurley, “The Escrts - Converging on Mechanism,” Journal of Cell Science 133, no. 18 (2020): jcs240333.

[145] J. Gruenberg, “Life in the Lumen: The Multivesicular Endosome,” Traffic 21, no. 1 (2020): 76–93.

[146] J. Meldolesi, “Unconventional Protein Secretion Dependent on Two Extracellular Vesicles: Exosomes and Ectosomes,” Frontiers in Cell and Developmental Biology 10 (2022): 877344.

[147] S. T. Huber, S. Mostafavi, S. A. Mortensen, and C. Sachse, “Structure and Assembly of Escrt-Iii Helical Vps24 Filaments,” Science Advances 6, no. 34 (2020): eaba4897.

[148] C. C. Tseng, S. Dean, B. A. Davies, et al., “Bro1 Stimulates Vps4 to Promote Intralumenal Vesicle Formation during Multivesicular Body Biogenesis,” Journal of Cell Biology 220, no. 8 (2021): e202102070.

[149] A. C. Borchers, M. Janz, J. H. Schäfer, et al., “Regulatory Sites in the Mon1-Ccz1 Complex Control Rab5 to Rab7 Transition and Endosome Maturation,” Proceedings of the National Academy of Sciences of the United States of America 120, no. 30 (2023): e2303750120.

[150] F. J. Verweij, M. P. Bebelman, A. E. George, et al., “Er Membrane Contact Sites Support Endosomal Small Gtpase Conversion for Exosome Secretion,” Journal of Cell Biology 221, no. 12 (2022): e202112032.

[151] D. Wei, W. Zhan, Y. Gao, et al., “Rab31 Marks and Controls an Escrt-Independent Exosome Pathway,” Cell Research 31, no. 2 (2020): 157–177.

[152] M. Raudenska, J. Balvan, and M. Masarik, “Crosstalk between Autophagy Inhibitors and Endosome-Related Secretory Pathways: A Challenge for Autophagy-Based Treatment of Solid Cancers,” Molecular Cancer 20, no. 1 (2021): 140.

[153] M. Ostrowski, N. B. Carmo, S. Krumeich, et al., “Rab27a and Rab27b Control Different Steps of the Exosome Secretion Pathway,” Nature Cell Biology 12, no. 1 (2010): 19–30; sup pp 1–13.

[154] S. B. Arya, S. P. Collie, and C. A. Parent, “The Ins-and-Outs of Exosome Biogenesis, Secretion, and Internalization,” Trends in Cell Biology 34, no. 2 (2024): 90–108.

[155] T. Matsui, Y. Sakamaki, S. Nakashima, and M. Fukuda, “Rab39 and Its Effector Uaca Regulate Basolateral Exosome Release from Polarized Epithelial Cells,” Cell Reports 39, no. 9 (2022): 110875.

[156] C. Liu, D. Liu, S. Wang, L. U. Gan, X. Yang, and C. Ma, “Identification of the Snare Complex That Mediates the Fusion of Multivesicular Bodies with the Plasma Membrane in Exosome Secretion,” Journal of Extracellular Vesicles 12, no. 9 (2023): e12356.

[157] Y. Qu, L. Franchi, G. Nunez, and G. R. Dubyak, “Nonclassical Il-1 Beta Secretion Stimulated by P2x7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages,” Journal of Immunology 179, no. 3 (2007): 1913–1925.

[158] K. Bulek, J. Zhao, Y. Liao, et al., “Epithelial-Derived Gasdermin D Mediates Nonlytic Il-1β Release during Experimental Colitis,” Journal of Clinical Investigation (2020): 4218–4234.

[159] E. E. Congdon and E. M. Sigurdsson, “Tau-Targeting Therapies for Alzheimer Disease,” Nature Reviews Neurology 14, no. 7 (2018): 399–415.

[160] J. Pilliod, M. Gélinas-Faucher, and N. Leclerc, “Unconventional Secretion of Tau by Vamp8 Impacts Its Intra- and Extracellular Cleavage,” Frontiers in Cell and Developmental Biology 10 (2022): 912118.

[161] H. Asai, S. Ikezu, S. Tsunoda, et al., “Depletion of Microglia and Inhibition of Exosome Synthesis Halt Tau Propagation,” Nature Neuroscience 18, no. 11 (2015): 1584–1593.

[162] K. Tieu, M. Cui, Q. Dong, et al., “Microglial Exosomes Facilitate Α-Synuclein Transmission in Parkinson's Disease,” Brain 143, no. 5 (2020): 1476–1497.

[163] C. Tricarico, J. Clancy, and C. D'Souza-Schorey, “Biology and Biogenesis of Shed Microvesicles,” Small GTPases 8, no. 4 (2017): 220–232.

[164] G. van Niel, G. D'Angelo, and G. C. A. Raposo, “Shedding Light on the Cell Biology of Extracellular Vesicles,” Nature Reviews Molecular Cell Biology 19, no. 4 (2018): 213–228.

[165] K. Al-Nedawi, B. Meehan, J. Micallef, et al., “Intercellular Transfer of the Oncogenic Receptor Egfrviii by Microvesicles Derived from Tumour Cells,” Nature Cell Biology 10, no. 5 (2008): 619–624.

[166] A. Piccin, W. G. Murphy, and O. P. Smith, “Circulating Microparticles: Pathophysiology and Clinical Implications,” Blood Reviews 21, no. 3 (2007): 157–171.

[167] B. Shen, Y. Fang, N. Wu, and S. J. Gould, “Biogenesis of the Posterior Pole Is Mediated by the Exosome/Microvesicle Protein-Sorting Pathway,” Journal of Biological Chemistry 286, no. 51 (2011): 44162–44176.

[168] J. M. Yang and S. J. Gould, “The Cis-Acting Signals That Target Proteins to Exosomes and Microvesicles,” Biochemical Society Transactions 41, no. 1 (2013): 277–282.

[169] R. E. McConnell, J. N. Higginbotham, D. A. Shifrin,, D. L. Tabb, R. J. Coffey, and M. J. Tyska, “The Enterocyte Microvillus Is a Vesicle-Generating Organelle,” Journal of Cell Biology 185, no. 7 (2009): 1285–1298.

[170] C. D'Souza-Schorey and J. W. Clancy, “Tumor-Derived Microvesicles: Shedding Light on Novel Microenvironment Modulators and Prospective Cancer Biomarkers,” Genes & development 26, no. 12 (2012): 1287–1299.

[171] J. Wang, X. Zhuang, K. S. Greene, et al., “Cdc42 Functions as a Regulatory Node for Tumour-Derived Microvesicle Biogenesis,” Journal of Extracellular Vesicles 10, no. 3 (2021): e12051.

[172] S. Maity, C. Caillat, N. Miguet, et al., “Vps4 Triggers Constriction and Cleavage of Escrt-Iii Helical Filaments,” Science Advances 5, no. 4 (2019): eaau7198.

[173] C. A. Moraes, E. D. Hottz, D. E. Dos Santos Ornellas, et al., “Microglial Nlrp3 Inflammasome Induces Excitatory Synaptic Loss through Il-1β-Enriched Microvesicle Release: Implications for Sepsis-Associated Encephalopathy,” Molecular Neurobiology 60, no. 2 (2022): 481–494.

[174] J. Avila, S. Dujardin, S. E. Bégard, et al., “Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein,” PLoS One 9, no. 6 (2014): e100760.

[175] L. Zhang, J. Gao, T. Chen, et al., “Microvesicles Derived from Human Embryonic Neural Stem Cells Inhibit the Apoptosis of Hl-1 Cardiomyocytes by Promoting Autophagy and Regulating Akt and Mtor via Transporting Hsp-70,” Stem Cells International 2019 (2019): 1–15.

[176] J. W. Clancy, M. Schmidtmann, and C. D'Souza-Schorey, “The Ins and Outs of Microvesicles,” FASEB Bioadvances 3, no. 6 (2021): 399–406.

[177] V. Muralidharan-Chari, J. Clancy, C. Plou, et al., “Arf6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles,” Current Biology 19, no. 22 (2009): 1875–1885.

[178] J. W. Clancy, C. J. Tricarico, D. R. Marous, and C. D'Souza-Schorey, “Coordinated Regulation of Intracellular Fascin Distribution Governs Tumor Microvesicle Release and Invasive Cell Capacity,” Molecular and Cellular Biology 39, no. 3 (2019): e00264-18.

[179] A. Rubartelli, F. Cozzolino, M. Talio, and R. Sitia, “A Novel Secretory Pathway for Interleukin-1 Beta, a Protein Lacking a Signal Sequence,” Embo Journal 9, no. 5 (1990): 1503–1510.

[180] C. Andrei, C. Dazzi, L. Lotti, M. R. Torrisi, G. Chimini, and A. Rubartelli, “The Secretory Route of the Leaderless Protein Interleukin 1beta Involves Exocytosis of Endolysosome-Related Vesicles,” Molecular Biology of the Cell 10, no. 5 (1999): 1463–1475.

[181] M. M. Harnett, M. A. Pineda, P. Latré de Laté, et al., “From Christian De Duve to Yoshinori Ohsumi: More to Autophagy than Just Dining at Home,” Biomedical Journal 40, no. 1 (2017): 9–22.

[182] K. Cadwell and J. Debnath, “Beyond Self-Eating: The Control of Nonautophagic Functions and Signaling Pathways by Autophagy-Related Proteins,” Journal of Cell Biology 217, no. 3 (2018): 813–822.

[183] T. A. Solvik, T. A. Nguyen, Y. U.-H. T. Lin, et al., “Secretory Autophagy Maintains Proteostasis Upon Lysosome Inhibition,” Journal of Cell Biology 221, no. 6 (2022): e202110151.

[184] N. P. Hessvik, A. Øverbye, A. Brech, et al., “Pikfyve Inhibition Increases Exosome Release and Induces Secretory Autophagy,” Cellular and Molecular Life Sciences 73, no. 24 (2016): 4717–4737.

[185] A. M. Miranda, Z. M. Lasiecka, Y. Xu, et al., “Neuronal Lysosomal Dysfunction Releases Exosomes Harboring App C-Terminal Fragments and Unique Lipid Signatures,” Nature Communications 9, no. 1 (2018): 291.

[186] J. M. Hyttinen, M. Niittykoski, A. Salminen, and K. Kaarniranta, “Maturation of Autophagosomes and Endosomes: A Key Role for Rab7,” Biochimica Et Biophysica Acta 1833, no. 3 (2013): 503–510.

[187] P. Ejlerskov, I. Rasmussen, T. T. Nielsen, et al., “Tubulin Polymerization-Promoting Protein (Tppp/P25α) Promotes Unconventional Secretion of Α-Synuclein through Exophagy by Impairing Autophagosome-Lysosome Fusion,” Journal of Biological Chemistry 288, no. 24 (2013): 17313–17335.

[188] Q. Li, G. Peng, H. Liu, L. Wang, R. Lu, and L. Li, “Molecular Mechanisms of Secretory Autophagy and Its Potential Role in Diseases,” Life Sciences 347 (2024): 122653.

[189] M. Zhang, S. J. Kenny, L. Ge, K. Xu, and R. Schekman, “Translocation of Interleukin-1β into a Vesicle Intermediate in Autophagy-Mediated Secretion,” Elife 4 (2015): e11205.

[190] C. Appenzeller-Herzog and H. P. Hauri, “The Er-Golgi Intermediate Compartment (Ergic): In Search of Its Identity and Function,” Journal of Cell Science 119, no. Pt 11 (2006): 2173–2183.

[191] H. Ben-Tekaya, K. Miura, R. Pepperkok, and H. P. Hauri, “Live Imaging of Bidirectional Traffic from the Ergic,” Journal of Cell Science 118, no. Pt 2 (2005): 357–367.

[192] Y. Sun, X. Tao, Y. Han, et al., “A Dual Role of Ergic-Localized Rabs in Tmed10-Mediated Unconventional Protein Secretion,” Nature Cell Biology 26, no. 7 (2024): 1077–1092.

[193] W. Zhang, C. Ji, X. Li, et al., “Autophagy-Independent Role of Atg9a Vesicles as Carriers for Galectin-9 Secretion,” Nature Communications 16, no. 1 (2025): 4259.

[194] J. Zheng, H. Wang, Y. Sun, et al., “Tmeds Mediate Versatile Cargo Transport in Vesicle-Dependent Unconventional Secretion,” Journal of Cell Biology 225, no. 1 (2026): e202503075.

[195] J. New and S. M. Thomas, “Autophagy-Dependent Secretion: Mechanism, Factors Secreted, and Disease Implications,” Autophagy 15, no. 10 (2019): 1682–1693.

[196] W. Sun, B. I.-X. Tian, S.-H. Wang, P.-J. Liu, and Y.-C. Wang, “The Function of Sec22b and Its Role in Human Diseases,” Cytoskeleton 77, no. 8 (2020): 303–312.

[197] T. Kimura, J. Jia, S. Kumar, et al., “Dedicated Snares and Specialized Trim Cargo Receptors Mediate Secretory Autophagy,” Embo Journal 36, no. 1 (2017): 42–60.

[198] S. Jiang, N. Dupont, E. F. Castillo, and V. Deretic, “Secretory versus Degradative Autophagy: Unconventional Secretion of Inflammatory Mediators,” Journal of Innate Immunity 5, no. 5 (2013): 471–479.

[199] D. Ganesan and Q. Cai, “Understanding Amphisomes,” Biochemical Journal 478, no. 10 (2021): 1959–1976.

[200] K. K. Patel, H. Miyoshi, W. L. Beatty, et al., “Autophagy Proteins Control Goblet Cell Function by Potentiating Reactive Oxygen Species Production,” Embo Journal 32, no. 24 (2013): 3130–3144.

[201] Y. D. Chen, Y. T. Fang, Y. L. Cheng, et al., “Exophagy of Annexin A2 via Rab11, Rab8a and Rab27a in Ifn-Γ-Stimulated Lung Epithelial Cells,” Scientific Reports 7, no. 1 (2017): 5676.

[202] M. Mauthe, I. Orhon, C. Rocchi, et al., “Chloroquine Inhibits Autophagic Flux by Decreasing Autophagosome-Lysosome Fusion,” Autophagy 14, no. 8 (2018): 1435–1455.

[203] H. Guo, M. Chitiprolu, L. Roncevic, et al., “Atg5 Disassociates the V(1)V(0)-Atpase to Promote Exosome Production and Tumor Metastasis Independent of Canonical Macroautophagy,” Developmental Cell 43, no. 6 (2017): 716–730.e7.

[204] Y. H. Kim, M. S. Kwak, B. Lee, et al., “Secretory Autophagy Machinery and Vesicular Trafficking Are Involved in Hmgb1 Secretion,” Autophagy 17, no. 9 (2020): 2345–2362.

[205] M. Ponpuak, M. A. Mandell, T. Kimura, and S. Chauhan, “Cédric Cleyrat, and Vojo Deretic. ‘’Secretory Autophagy,” Current Opinion in Cell Biology 35 (2015): 106–116.

[206] G. Cavalli and S. Cenci, “Autophagy and Protein Secretion,” Journal of Molecular Biology 432, no. 8 (2020): 2525–2545.

[207] E. Zubkova, A. Kalinin, A. Bolotskaya, I. Beloglazova, and M. Menshikov, “Autophagy-Dependent Secretion: Crosstalk between Autophagy and Exosome Biogenesis,” Current Issues in Molecular Biology 46, no. 3 (2024): 2209–2235.

[208] D. Cruz-Garcia, A. J. Curwin, J.-F. C. Popoff, C. Bruns, J. M. Duran, and V. Malhotra, “Remodeling of Secretory Compartments Creates Cups during Nutrient Starvation,” Journal of Cell Biology 207, no. 6 (2014): 695–703.

[209] A. J. Curwin, K. Kurokawa, G. Bigliani, N. Brouwers, A. Nakano, and V. Malhotra, “The Pathway of Unconventional Protein Secretion Involves Cups and a Modified Trans-Golgi Network,” Journal of Cell Biology 224, no. 5 (2025): e202312120.

[210] C. Bruns, J. Michael McCaffery, A. J. Curwin, J. M. Duran, and V. Malhotra, “Biogenesis of a Novel Compartment for Autophagosome-Mediated Unconventional Protein Secretion,” Journal of Cell Biology 195, no. 6 (2011): 979–992.

[211] L. F. S. Mendes, C. O. Gimenes, M. I. D. O. Silva, S. K. Rout, R. Riek, and A. J. Costa-Filho, “The Potential Role of Liquid–Liquid Phase Separation in the Cellular Fate of the Compartments for Unconventional Protein Secretion,” Protein Science 33, no. 7 (2024): e5085.

[212] A. J. Curwin, N. Brouwers, M. A. Y. Adell, et al., “Escrt-Iii Drives the Final Stages of Cups Maturation for Unconventional Protein Secretion,” Elife 5 (2016): e16299.

[213] J. Nüchel, M. Tauber, J. L. Nolte, et al., “An Mtorc1-Grasp55 Signaling Axis Controls Unconventional Secretion to Reshape the Extracellular Proteome Upon Stress,” Molecular Cell 81, no. 16 (2021): 3275–3293.e12.

[214] X. Zhang, L. Wang, B. Lak, J. Li, E. Jokitalo, and Y. Wang, “Grasp55 Senses Glucose Deprivation through O-Glcnacylation to Promote Autophagosome-Lysosome Fusion,” Developmental Cell 45, no. 2 (2018): 245–261.e6.

[215] D. Cruz-Garcia, N. Brouwers, J. M. Duran, G. Mora, A. J. Curwin, and V. Malhotra, “A Diacidic Motif Determines Unconventional Secretion of Wild-Type and Als-Linked Mutant Sod1,” Journal of Cell Biology 216, no. 9 (2017): 2691–2700.

[216] D. Cruz-Garcia, V. Malhotra, and A. J. Curwin, “Unconventional Protein Secretion Triggered by Nutrient Starvation,” Seminars in Cell & Developmental Biology 83 (2018): 22–28.

[217] J. M. Duran, C. Anjard, C. Stefan, W. F. Loomis, and V. Malhotra, “Unconventional Secretion of Acb1 Is Mediated by Autophagosomes,” Journal of Cell Biology 188, no. 4 (2010): 527–236.

[218] A. M. Leidal, H. H. Huang, T. Marsh, et al., “The Lc3-Conjugation Machinery Specifies the Loading of Rna-Binding Proteins into Extracellular Vesicles,” Nature Cell Biology 22, no. 2 (2020): 187–199.

[219] J. O. Gardner, A. M. Leidal, T. A. Nguyen, and J. Debnath, “Lc3-Dependent Ev Loading and Secretion (Ldels) Promotes Tfrc (Transferrin Receptor) Secretion via Extracellular Vesicles,” Autophagy 19, no. 5 (2022): 1551–1561.

[220] J. Debnath and A. M. Leidal, “Secretory Autophagy during Lysosome Inhibition (Sali),” Autophagy 18, no. 10 (2022): 2498–2499.

[221] T. Noda and Y. Ohsumi, “Tor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast,” Journal of Biological Chemistry 273, no. 7 (1998): 3963–3966.

[222] Y. Kamada, T. Funakoshi, T. Shintani, K. Nagano, M. Ohsumi, and Y. Ohsumi, “Tor-Mediated Induction of Autophagy via an Apg1 Protein Kinase Complex,” Journal of Cell Biology 150, no. 6 (2000): 1507–1513.

[223] K. Suzuki, T. Kirisako, Y. Kamada, N. Mizushima, T. Noda, and Y. Ohsumi, “The Pre-Autophagosomal Structure Organized by Concerted Functions of Apg Genes Is Essential for Autophagosome Formation,” Embo Journal 20, no. 21 (2001): 5971–5981.

[224] Y. Fujioka, J. M. Alam, D. Noshiro, et al., “Phase Separation Organizes the Site of Autophagosome Formation,” Nature 578, no. 7794 (2020): 301–305.

[225] J. Debnath, N. Gammoh, and K. M. Ryan, “Autophagy and Autophagy-Related Pathways in Cancer,” Nature Reviews Molecular Cell Biology 24, no. 8 (2023): 560–575.

[226] X. Ding, X. Jiang, R. Tian, et al., “Rab2 Regulates the Formation of Autophagosome and Autolysosome in Mammalian Cells,” Autophagy 15, no. 10 (2019): 1774–1786.

[227] N. Fujita, T. Itoh, H. Omori, M. Fukuda, T. Noda, and T. Yoshimori, “The Atg16l Complex Specifies the Site of Lc3 Lipidation for Membrane Biogenesis in Autophagy,” Molecular Biology of the Cell 19, no. 5 (2008): 2092–2100.

[228] Y. Sheng, Y. Song, Z. Li, et al., “Rab37 Interacts Directly with Atg5 and Promotes Autophagosome Formation via Regulating Atg5-12-16 Complex Assembly,” Cell Death and Differentiation 25, no. 5 (2018): 918–934.

[229] Y. Fujioka, T. Tsuji, T. Kotani, et al. “Phase Separation Promotes Atg8 Lipidation for Autophagy Progression.” (2024): 2024.08. 29.610189.

[230] S. Maeda, H. Yamamoto, L. N. Kinch, et al., “Structure, Lipid Scrambling Activity and Role in Autophagosome Formation of Atg9a,” Nature Structural & Molecular Biology 27, no. 12 (2020): 1194–1201.

[231] K. Matoba, T. Kotani, A. Tsutsumi, et al., “Atg9 Is a Lipid Scramblase That Mediates Autophagosomal Membrane Expansion,” Nature Structural & Molecular Biology 27, no. 12 (2020): 1185–1193.

[232] S. Maeda, C. Otomo, and T. Otomo, “The Autophagic Membrane Tether Atg2a Transfers Lipids between Membranes,” Elife 8 (2019): e45777.

[233] D. P. Valverde, S. Yu, V. Boggavarapu, et al., “Atg2 Transports Lipids to Promote Autophagosome Biogenesis,” Journal of Cell Biology 218, no. 6 (2019): 1787–1798.

[234] T. Osawa, T. Kotani, T. Kawaoka, et al., “Atg2 Mediates Direct Lipid Transfer between Membranes for Autophagosome Formation,” Nature Structural & Molecular Biology 26, no. 4 (2019): 281–288.

[235] M. J. Mallén-Ponce, S. Gámez-Arcas, and M. I. A. E. Pérez-Pérez, “Redox Partner Interactions in the Atg8 Lipidation System in Microalgae,” Free Radical Biology and Medicine 203 (2023): 58–68.

[236] Y. Fujioka and N. N. Noda, “Mechanisms of Autophagosome Formation,” Proceedings of the Japan Academy, Series B 101, no. 1 (2025): 32–40.

[237] J. G. Lee, S. Takahama, G. Zhang, S. I. Tomarev, and Y. Ye, “Unconventional Secretion of Misfolded Proteins Promotes Adaptation to Proteasome Dysfunction in Mammalian Cells,” Nature Cell Biology 18, no. 7 (2016): 765–776.

[238] L. Wang, Y. Xu, T. Fukushige, et al., “Mono-Ufmylation Promotes Misfolding-Associated Secretion of Α-Synuclein,” Science Advances 10, no. 11 (2024): eadk2542.

[239] S. Wu, N. C. H. Villegas, D. W. Sirkis, I. Thomas-Wright, R. Wade-Martins, and R. Schekman, “Unconventional Secretion of Α-Synuclein Mediated by Palmitoylated Dnajc5 Oligomers,” Elife 12 (2023): e85837.

[240] S. Martinelli, E. A. Anderzhanova, T. Bajaj, et al., “Stress-Primed Secretory Autophagy Promotes Extracellular Bdnf Maturation by Enhancing Mmp9 Secretion,” Nature Communications 12, no. 1 (2021): 4643.

[241] S.-Y. Wu, Y. I.-C. Wang, R. Zuchini, K.-Y. Lan, H.-S. Liu, and S.-H. Lan, “Secretory Autophagy-Promoted Cargo Exocytosis Requires Active Rab37,” Autophagy 20, no. 4 (2023): 933–934.

[242] S. Y. Wu, H. T. Wu, Y. C. Wang, et al., “Secretory Autophagy Promotes Rab37-Mediated Insulin Secretion under Glucose Stimulation both in Vitro and in Vivo,” Autophagy 19, no. 4 (2023): 1239–1257.

[243] D. Shvarev, J. Schoppe, C. König, et al., “Structure of the Hops Tethering Complex, a Lysosomal Membrane Fusion Machinery,” Elife 11 (2022): e80901.

[244] Y. Zhang, H. Sun, R. Pei, et al., “The Sars-Cov-2 Protein Orf3a Inhibits Fusion of Autophagosomes with Lysosomes,” Cell Discovery 7, no. 1 (2021): 31.

[245] P. Hou, X. Wang, H. Wang, et al., “The Orf7a Protein of Sars-Cov-2 Initiates Autophagy and Limits Autophagosome-Lysosome Fusion via Degradation of Snap29 to Promote Virus Replication,” Autophagy 19, no. 2 (2023): 551–569.

[246] X. Li, B. Liu, Y. Wen, et al., “Coordination of Rab-8 and Rab-11 during Unconventional Protein Secretion,” Journal of Cell Biology 223, no. 2 (2024): e202306107.

[247] T. Ding, J. Ji, W. Zhang, et al., “The Phosphatidylinositol (4,5)-Bisphosphate-Rab35 Axis Regulates Migrasome Formation,” Cell Research 33, no. 8 (2023): 617–627.

[248] C. M. Fader, D. Sánchez, M. Furlán, and M. I. Colombo, “Induction of Autophagy Promotes Fusion of Multivesicular Bodies with Autophagic Vacuoles in K562 Cells,” Traffic 9, no. 2 (2008): 230–250.

[249] S. Y. Wu, J. W. Chen, H. Y. Liu, et al., “Secretory Autophagy Promotes Rab37-Mediated Exocytosis of Tissue Inhibitor of Metalloproteinase 1,” Journal of Biomedical Science 29, no. 1 (2022): 103.

[250] P. Stanley, “Golgi Glycosylation,” Cold Spring Harbor Perspectives in Biology 3, no. 4 (2011): a005199.

[251] A. G. Grieve and C. Rabouille, “Golgi Bypass: Skirting around the Heart of Classical Secretion,” Cold Spring Harbor Perspectives in Biology 3, no. 4 (2011): a005298–a98.

[252] F. A. Barr, M. Puype, J. Vandekerckhove, and G. Warren, “Grasp65, a Protein Involved in the Stacking of Golgi Cisternae,” Cell 91, no. 2 (1997): 253–262.

[253] J. Shorter, R. Watson, M. E. Giannakou, M. Clarke, G. Warren, and F. A. Barr, “Grasp55, a Second Mammalian Grasp Protein Involved in the Stacking of Golgi Cisternae in a Cell-Free System,” Embo Journal 18, no. 18 (1999): 4949–4960.

[254] H. Schotman, L. Karhinen, and C. Rabouille, “Dgrasp-Mediated Noncanonical Integrin Secretion Is Required for Drosophila Epithelial Remodeling,” Developmental Cell 14, no. 2 (2008): 171–182.

[255] S. T. Truschel, D. Sengupta, A. Foote, A. Heroux, M. R. Macbeth, and A. D. Linstedt, “Structure of the Membrane-Tethering Grasp Domain Reveals a Unique Pdz Ligand Interaction That Mediates Golgi Biogenesis,” Journal of Biological Chemistry 286, no. 23 (2011): 20125–20129.

[256] J. Kim, S. H. Noh, H. E. Piao, et al., “Monomerization and Er Relocalization of Grasp Is a Requisite for Unconventional Secretion of Cftr,” Traffic 17, no. 7 (2016): 733–753.

[257] M. D. Amaral, C. M. Farinha, P. Matos, and H. M. Botelho, “Investigating Alternative Transport of Integral Plasma Membrane Proteins from the Er to the Golgi: Lessons from the Cystic Fibrosis Transmembrane Conductance Regulator (Cftr),” Methods in Molecular Biology 1459 (2016): 105–126.

[258] S. H. Cheng, R. J. Gregory, J. Marshall, et al., “Defective Intracellular Transport and Processing of Cftr Is the Molecular Basis of Most Cystic Fibrosis,” Cell 63, no. 4 (1990): 827–834.

[259] C. M. Farinha, L. U. Santos, and J. O. A. O. F. Ferreira, “Cell Type-Specific Regulation of Cftr Trafficking—on the Verge of Progress,” Frontiers in Cell and Developmental Biology 12 (2024): 1338892.

[260] H. Park, D. H. Shin, J. R. Sim, S. Aum, and M. G. Lee, “Ire1α Kinase-Mediated Unconventional Protein Secretion Rescues Misfolded Cftr and Pendrin,” Science Advances 6, no. 8 (2020): eaax9914.

[261] M. S. Song, H. J. Sim, S. H. O. Eun, et al., “Tubular Er Structures Shaped by Er-Phagy Receptors Engage in Stress-Induced Golgi Bypass,” Developmental Cell (2025): 1568–1585.e11.

[262] S. H. O. Eun, S. H. Noh, and M. G. Lee, “Specific Kinesin and Dynein Molecules Participate in the Unconventional Protein Secretion of Transmembrane Proteins,” The Korean Journal of Physiology & Pharmacology 28, no. 5 (2024): 435–447.

[263] K. Yamada, S. Motohashi, T. Oikawa, et al., “Extended-Synaptotagmin 1 Engages in Unconventional Protein Secretion Mediated via Sec22b(+) Vesicle Pathway in Liver Cancer,” Proceedings of the National Academy of Sciences of the United States of America 119, no. 36 (2022): e2202730119.

[264] J. Jung, J. Kim, S. H. Roh, et al., “The Hsp70 Co-Chaperone Dnajc14 Targets Misfolded Pendrin for Unconventional Protein Secretion,” Nature Communications 7, no. 1 (2016): 11386.

[265] G. Tian, P. Ropelewski, I. Nemet, R. Lee, K. H. Lodowski, and Y. Imanishi, “An Unconventional Secretory Pathway Mediates the Cilia Targeting of Peripherin/Rds,” Journal of Neuroscience 34, no. 3 (2014): 992–1006.

[266] M. Grieben, A. C. W. Pike, C. A. Shintre, et al., “Structure of the Polycystic Kidney Disease Trp Channel Polycystin-2 (Pc2),” Nature Structural & Molecular Biology 24, no. 2 (2017): 114–122.

[267] C. González, V. I. Hugo Cornejo, and A. E. S. Couve, “Golgi Bypass for Local Delivery of Axonal Proteins, Fact or Fiction?” Current Opinion in Cell Biology 53 (2018): 9–14.

[268] I. Erler, D. M. M. Al-Ansary, U. Wissenbach, T. F. J. Wagner, V. Flockerzi, and B. A. Niemeyer, “Trafficking and Assembly of the Cold-Sensitive Trpm8 Channel*,” Journal of Biological Chemistry 281, no. 50 (2006): 38396–38404.

[269] D. Ghosh, S. Pinto, L. Danglot, et al., “Vamp7 Regulates Constitutive Membrane Incorporation of the Cold-Activated Channel Trpm8,” Nature Communications 7 (2016): 10489.

[270] H. Kamiguchi and V. Lemmon, “Recycling of the Cell Adhesion Molecule L1 in Axonal Growth Cones,” Journal of Neuroscience 20, no. 10 (2000): 3676–3686.

[271] P. Alberts, R. Rudge, T. Irinopoulou, L. Danglot, C. Gauthier-Rouvière, and T. Galli, “Cdc42 and Actin Control Polarized Expression of Ti-Vamp Vesicles to Neuronal Growth Cones and Their Fusion with the Plasma Membrane,” Molecular Biology of the Cell 17, no. 3 (2006): 1194–1203.

[272] J. Eswaran, E. Koronakis, M. K. Higgins, C. Hughes, and V. Koronakis, “Three's Company: Component Structures Bring a Closer View of Tripartite Drug Efflux Pumps,” Current Opinion in Structural Biology 14, no. 6 (2004): 741–747.

[273] M. Lee, S. Y. Jun, B. Y. Yoon, S. Song, K. Lee, and N. C. Ha, “Membrane Fusion Proteins of Type I Secretion System and Tripartite Efflux Pumps Share a Binding Motif for Tolc in Gram-Negative Bacteria,” PLoS One 7, no. 7 (2012): e40460.

[274] M. F. Symmons, R. L. Marshall, and V. N. Bavro, “Architecture and Roles of Periplasmic Adaptor Proteins in Tripartite Efflux Assemblies,” Frontiers in Microbiology 6 (2015): 513.

[275] J. S. Kim, S. Song, M. Lee, S. Lee, K. Lee, and N. C. Ha, “Crystal Structure of a Soluble Fragment of the Membrane Fusion Protein Hlyd in a Type I Secretion System of Gram-Negative Bacteria,” Structure 24, no. 3 (2016): 477–485.

[276] V. Koronakis, A. Sharff, E. Koronakis, B. Luisi, and C. Hughes, “Crystal Structure of the Bacterial Membrane Protein Tolc Central to Multidrug Efflux and Protein Export,” Nature 405, no. 6789 (2000): 914–919.

[277] X. Y. Pei, P. Hinchliffe, M. F. Symmons, et al., “Structures of Sequential Open States in a Symmetrical Opening Transition of the Tolc Exit Duct,” Proceedings of the National Academy of Sciences of the United States of America 108, no. 5 (2011): 2112–2117.

[278] C. Andersen, E. Koronakis, E. Bokma, et al., “Transition to the Open State of the Tolc Periplasmic Tunnel Entrance,” Proceedings of the National Academy of Sciences of the United States of America 99, no. 17 (2002): 11103–11108.

[279] H. Zhao, J. Lee, and J. Chen, “The Hemolysin a Secretion System Is a Multi-Engine Pump Containing Three Abc Transporters,” Cell 185, no. 18 (2022): 3329–3340.e13.

[280] T. Thanabalu, E. Koronakis, C. Hughes, and V. Koronakis, “Substrate-Induced Assembly of a Contiguous Channel for Protein Export from E.Coli: Reversible Bridging of an Inner-Membrane Translocase to an Outer Membrane Exit Pore,” Embo Journal 17, no. 22 (1998): 6487–6496.

[281] L. Gray, N. Mackman, J. M. Nicaud, and I. B. Holland, “The Carboxy-Terminal Region of Haemolysin 2001 Is Required for Secretion of the Toxin from Escherichia Coli,” Molecular & General Genetics 205, no. 1 (1986): 127–133.

[282] L. Balakrishnan, C. Hughes, and V. Koronakis, “Substrate-Triggered Recruitment of the Tolc Channel-Tunnel during Type I Export of Hemolysin by Escherichia Coli,” Journal of Molecular Biology 313, no. 3 (2001): 501–510.

[283] H. E. Jones, I. B. Holland, H. L. Baker, and A. K. Campbell, “Slow Changes in Cytosolic Free Ca2+ in Escherichia Coli Highlight Two Putative Influx Mechanisms in Response to Changes in Extracellular Calcium,” Cell Calcium 25, no. 3 (1999): 265–274.

[284] F. J. Hodges, V. V. L. Torres, A. F. Cunningham, I. R. Henderson, and C. Icke, “Redefining the Bacterial Type I Protein Secretion System,” Advances in Microbial Physiology 82 (2023): 155–204.

[285] T. Ibuki, K. Imada, T. Minamino, T. Kato, T. Miyata, and K. Namba, “Common Architecture of the Flagellar Type Iii Protein Export Apparatus and F- and V-Type Atpases,” Nature Structural & Molecular Biology 18, no. 3 (2011): 277–282.

[286] M. Lara-Tejero, J. Kato, S. Wagner, X. Liu, and J. E. Galán, “A Sorting Platform Determines the Order of Protein Secretion in Bacterial Type Iii Systems,” Science 331, no. 6021 (2011): 1188–1191.

[287] B. Hu, M. Lara-Tejero, Q. Kong, J. E. Galán, and J. Liu, “In Situ Molecular Architecture of the Salmonella Type Iii Secretion Machine,” Cell 168, no. 6 (2017): 1065–1074.e10.

[288] Y. Zhang, M. Lara-Tejero, J. Bewersdorf, and J. E. Galán, “Visualization and Characterization of Individual Type Iii Protein Secretion Machines in Live Bacteria,” Proceedings of the National Academy of Sciences of the United States of America 114, no. 23 (2017): 6098–6103.

[289] T. Kubori, A. Sukhan, S. I. Aizawa, and J. E. Galán, “Molecular Characterization and Assembly of the Needle Complex of the Salmonella Typhimurium Type Iii Protein Secretion System,” Proceedings of the National Academy of Sciences of the United States of America 97, no. 18 (2000): 10225–10230.

[290] Y. Akeda and J. E. Galán, “Chaperone Release and Unfolding of Substrates in Type Iii Secretion,” Nature 437, no. 7060 (2005): 911–915.

[291] J. Magdalena, A. Hachani, M. Chamekh, et al., “Spa32 Regulates a Switch in Substrate Specificity of the Type Iii Secreton of Shigella Flexneri from Needle Components to Ipa Proteins,” Journal of Bacteriology 184, no. 13 (2002): 3433–3441.

[292] E. Z. Guo and J. E. Galán, “Cryo-Em Structure of the Needle Filament Tip Complex of the Salmonella Type Iii Secretion Injectisome,” Proceedings of the National Academy of Sciences of the United States of America 118, no. 44 (2021): e2114552118.

[293] D. Park, M. Lara-Tejero, M. N. Waxham, et al., “Visualization of the Type Iii Secretion Mediated Salmonella-Host Cell Interface Using Cryo-Electron Tomography,” Elife 7 (2018): e39514.

[294] J. E. Galán, “Common Themes in the Design and Function of Bacterial Effectors,” Cell Host & Microbe 5, no. 6 (2009): 571–579.

[295] T. A. Agbor and B. A. McCormick, “Salmonella Effectors: Important Players Modulating Host Cell Function during Infection,” Cellular Microbiology 13, no. 12 (2011): 1858–1869.

[296] P. G. Leiman, M. Basler, U. A. Ramagopal, et al., “Type Vi Secretion Apparatus and Phage Tail-Associated Protein Complexes Share a Common Evolutionary Origin,” Proceedings of the National Academy of Sciences of the United States of America 106, no. 11 (2009): 4154–4159.

[297] S. Pukatzki, A. T. Ma, A. T. Revel, D. Sturtevant, and J. J. Mekalanos, “Type Vi Secretion System Translocates a Phage Tail Spike-Like Protein into Target Cells Where It Cross-Links Actin,” Proceedings of the National Academy of Sciences of the United States of America 104, no. 39 (2007): 15508–15513.

[298] C. Rapisarda, Y. Cherrak, R. Kooger, et al., “In Situ and High-Resolution Cryo-Em Structure of a Bacterial Type Vi Secretion System Membrane Complex,” Embo Journal 38, no. 10 (2019): e100886.

[299] P. Bernal, R. C. D. Furniss, S. Fecht, et al., “A Novel Stabilization Mechanism for the Type Vi Secretion System Sheath,” Proceedings of the National Academy of Sciences of the United States of America 118, no. 7 (2021): e2008500118.

[300] Y. Cherrak, C. Rapisarda, R. Pellarin, et al., “Biogenesis and Structure of a Type Vi Secretion Baseplate,” Nature Microbiology 3, no. 12 (2018): 1404–1416.

[301] S. R. Dix, H. J. Owen, R. Sun, et al., “Structural Insights into the Function of Type Vi Secretion System Tssa Subunits,” Nature Communications 9, no. 1 (2018): 4765.

[302] Y. G. Santin, T. Doan, R. Lebrun, L. Espinosa, L. Journet, and E. Cascales, “In Vivo Tssa Proximity Labelling during Type Vi Secretion Biogenesis Reveals Taga as a Protein That Stops and Holds the Sheath,” Nature Microbiology 3, no. 11 (2018): 1304–1313.

[303] S. Nazarov, J. P. Schneider, M. Brackmann, K. N. Goldie, H. Stahlberg, and M. Basler, “Cryo-Em Reconstruction of Type Vi Secretion System Baseplate and Sheath Distal End,” Embo Journal 37, no. 4 (2018): e97103.

[304] O. Salih, S. He, S. Planamente, et al., “Atomic Structure of Type Vi Contractile Sheath from Pseudomonas Aeruginosa,” Structure 26, no. 2 (2018): 329–336.e3.

[305] J. D. Mougous, M. E. Cuff, S. Raunser, et al., “A Virulence Locus of Pseudomonas Aeruginosa Encodes a Protein Secretion Apparatus,” Science 312, no. 5779 (2006): 1526–1530.

[306] M. M. Shneider, S. A. Buth, B. T. Ho, M. Basler, J. J. Mekalanos, and P. G. Leiman, “Paar-Repeat Proteins Sharpen and Diversify the Type Vi Secretion System Spike,” Nature 500, no. 7462 (2013): 350–353.

[307] J. P. Schneider, S. Nazarov, R. Adaixo, et al., “Diverse Roles of Tssa-Like Proteins in the Assembly of Bacterial Type Vi Secretion Systems,” Embo Journal 38, no. 18 (2019): e100825.

[308] N. M. Taylor, N. S. Prokhorov, R. C. Guerrero-Ferreira, et al., “Structure of the T4 Baseplate and Its Function in Triggering Sheath Contraction,” Nature 533, no. 7603 (2016): 346–352.

[309] E. Durand, V. S. Nguyen, A. Zoued, et al., “Biogenesis and Structure of a Type Vi Secretion Membrane Core Complex,” Nature 523, no. 7562 (2015): 555–560.

[310] A. B. Russell, R. D. Hood, N. K. Bui, M. LeRoux, W. Vollmer, and J. D. Mougous, “Type Vi Secretion Delivers Bacteriolytic Effectors to Target Cells,” Nature 475, no. 7356 (2011): 343–347.

[311] C. Poulsen, S. Panjikar, S. J. Holton, M. Wilmanns, and Y. H. Song, “Wxg100 Protein Superfamily Consists of Three Subfamilies and Exhibits an Α-Helical C-Terminal Conserved Residue Pattern,” PLoS One 9, no. 2 (2014): e89313.

[312] M. H. Daleke, R. Ummels, P. Bawono, et al., “General Secretion Signal for the Mycobacterial Type Vii Secretion Pathway,” Proceedings of the National Academy of Sciences of the United States of America 109, no. 28 (2012): 11342–11347.

[313] T. H. Phan, L. M. van Leeuwen, C. Kuijl, et al., “Esph Is a Hypervirulence Factor for Mycobacterium Marinum and Essential for the Secretion of the Esx-1 Substrates Espe and Espf,” Plos Pathogens 14, no. 8 (2018): e1007247.

[314] M. H. Daleke, A. D. van der Woude, A. H. Parret, et al., “Specific Chaperones for the Type Vii Protein Secretion Pathway,” Journal of Biological Chemistry 287, no. 38 (2012): 31939–31947.

[315] N. Korotkova, D. Freire, T. H. Phan, et al., “Structure of the Mycobacterium Tuberculosis Type Vii Secretion System Chaperone Espg5 in Complex with Pe25-Ppe41 Dimer,” Molecular Microbiology 94, no. 2 (2014): 367–382.

[316] T. H. Phan and E. N. G. Houben, “Bacterial Secretion Chaperones: The Mycobacterial Type Vii Case,” Fems Microbiology Letters 365, no. 18 (2018): fny197.

[317] Z. Y. Jiang and J. P. Xie, “Progress on the Function of Mycobacterium T7ss (Esx) Secretion System,” Yi Chuan 45, no. 12 (2023): 1100–1113.

[318] A. Rivera-Calzada, N. Famelis, O. Llorca, and S. Geibel, “Type Vii Secretion Systems: Structure, Functions and Transport Models,” Nature Reviews Microbiology 19, no. 9 (2021): 567–584.

[319] U. Tak, T. Dokland, and M. Niederweis, “Pore-Forming Esx Proteins Mediate Toxin Secretion by Mycobacterium Tuberculosis,” Nature Communications 12, no. 1 (2021): 394.

[320] W. Frigui, D. Bottai, L. Majlessi, et al., “Control of M. Tuberculosis Esat-6 Secretion and Specific T Cell Recognition by Phop,” Plos Pathogens 4, no. 2 (2008): e33.

[321] J. E. Soto, J. E. Galán, and M. Lara-Tejero, “Assembly and Architecture of the Type Iii Secretion Sorting Platform,” Proceedings of the National Academy of Sciences of the United States of America 119, no. 51 (2022): e2218010119.

[322] W. P. J. Smith, A. Vettiger, J. Winter, et al., “The Evolution of the Type Vi Secretion System as a Disintegration Weapon,” Plos Biology 18, no. 5 (2020): e3000720.

[323] L. S. Ma, A. Hachani, J. S. Lin, A. Filloux, and E. M. Lai, “Agrobacterium Tumefaciens Deploys a Superfamily of Type Vi Secretion Dnase Effectors as Weapons for Interbacterial Competition in Planta,” Cell Host & Microbe 16, no. 1 (2014): 94–104.

[324] X. Liang, R. Moore, M. Wilton, M. J. Wong, L. Lam, and T. G. Dong, “Identification of Divergent Type Vi Secretion Effectors Using a Conserved Chaperone Domain,” Proceedings of the National Academy of Sciences of the United States of America 112, no. 29 (2015): 9106–9111.

[325] P. C. Lee and A. Rietsch, “Fueling Type Iii Secretion,” Trends in Microbiology 23, no. 5 (2015): 296–300.

[326] D. Ruano-Gallego, J. Sanchez-Garrido, Z. Kozik, et al., “Type Iii Secretion System Effectors Form Robust and Flexible Intracellular Virulence Networks,” Science 371, no. 6534 (2021): eabc9531.

[327] T. Ishikawa, D. Sabharwal, J. Bröms, et al., “Pathoadaptive Conditional Regulation of the Type Vi Secretion System in Vibrio Cholerae O1 Strains,” Infection and Immunity 80, no. 2 (2012): 575–584.

[328] J. A. Moscoso, H. Mikkelsen, S. Heeb, P. Williams, and A. Filloux, “The Pseudomonas Aeruginosa Sensor Rets Switches Type Iii and Type Vi Secretion via C-Di-Gmp Signalling,” Environmental Microbiology 13, no. 12 (2011): 3128–3138.

[329] W. Zhang, S. Xu, J. Li, X. Shen, Y. Wang, and Z. Yuan, “Modulation of a Thermoregulated Type Vi Secretion System by Ahl-Dependent Quorum Sensing in Yersinia Pseudotuberculosis,” Archives of Microbiology 193, no. 5 (2011): 351–363.

[330] G. Cao, S. T. Howard, P. Zhang, et al., “Espr, a Regulator of the Esx-1 Secretion System in Mycobacterium Tuberculosis, Is Directly Regulated by the Two-Component Systems Mprab and Phopr,” Microbiology (Reading) 161, no. Pt 3 (2015): 477–489.

[331] A. M. Abdallah, E. M. Weerdenburg, Q. Guan, et al., “Integrated Transcriptomic and Proteomic Analysis of Pathogenic Mycobacteria and Their Esx-1 Mutants Reveal Secretion-Dependent Regulation of Esx-1 Substrates and Whib6 as a Transcriptional Regulator,” PLoS One 14, no. 1 (2019): e0211003.

[332] S. S. Abby and E. P. Rocha, “The Non-Flagellar Type Iii Secretion System Evolved from the Bacterial Flagellum and Diversified into Host-Cell Adapted Systems,” Plos Genetics 8, no. 9 (2012): e1002983.

[333] Y. R. Brunet, J. Hénin, H. Celia, and E. Cascales, “Type Vi Secretion and Bacteriophage Tail Tubes Share a Common Assembly Pathway,” Embo Reports 15, no. 3 (2014): 315–321.

[334] C. Parsot, C. Hamiaux, and A. L. Page, “The Various and Varying Roles of Specific Chaperones in Type Iii Secretion Systems,” Current Opinion in Microbiology 6, no. 1 (2003): 7–14.

[335] B. J. Burkinshaw, X. Liang, M. Wong, A. N. H. Le, L. Lam, and T. G. Dong, “A Type Vi Secretion System Effector Delivery Mechanism Dependent on Paar and a Chaperone-Co-Chaperone Complex,” Nature Microbiology 3, no. 5 (2018): 632–640.

[336] B. Hu, D. R. Morado, W. Margolin, et al., “Visualization of the Type Iii Secretion Sorting Platform of Shigella Flexneri,” Proceedings of the National Academy of Sciences of the United States of America 112, no. 4 (2015): 1047–1052.

[337] V. Bachmann, B. Kostiuk, D. Unterweger, L. Diaz-Satizabal, S. Ogg, and S. Pukatzki, “Bile Salts Modulate the Mucin-Activated Type Vi Secretion System of Pandemic Vibrio Cholerae,” Public Library of Science Neglected Tropical Diseases 9, no. 8 (2015): e0004031.

[338] S. Wettstadt, T. E. Wood, S. Fecht, and A. Filloux, “Delivery of the Pseudomonas Aeruginosa Phospholipase Effectors Plda and Pldb in a Vgrg- and H2-T6ss-Dependent Manner,” Frontiers in Microbiology 10 (2019): 1718.

[339] M. M. Osman, A. J. Pagán, J. K. Shanahan, and L. Ramakrishnan, “Mycobacterium Marinum Phthiocerol Dimycocerosates Enhance Macrophage Phagosomal Permeabilization and Membrane Damage,” PLoS One 15, no. 7 (2020): e0233252.

[340] M. L. Burts, W. A. Williams, K. DeBord, and D. M. Missiakas, “Esxa and Esxb Are Secreted by an Esat-6-Like System That Is Required for the Pathogenesis of Staphylococcus Aureus Infections,” Proceedings of the National Academy of Sciences of the United States of America 102, no. 4 (2005): 1169–1174.

[341] R. Gentile, S. Schott-Verdugo, S. Khosa, et al., “Molecular Insights into Cld Domain Dynamics and Toxin Recruitment of the Hlya E. Coli T1ss,” Journal of Molecular Biology 437, no. 24 (2025): 169485.

[342] I. N. Erenburg, S. Hänsch, F. M. Chacko, et al., “Heterologously Secreted Mbxa from Moraxella Bovis Induces a Membrane Blebbing Response of the Human Host Cell,” Scientific Reports 12, no. 1 (2022): 17825.

[343] B. Barlag and M. Hensel, “The Giant Adhesin Siie of Salmonella Enterica,” Molecules 20, no. 1 (2015): 1134–1150.

[344] Y. Guo, D. Gu, T. Huang, et al., “Salmonella Enteritidis T1ss Protein Siid Inhibits Nlrp3 Inflammasome Activation via Repressing the Mtros-Asc Dependent Pathway,” Plos Pathogens 19, no. 5 (2023): e1011381.

[345] M. Yang, X. Zhou, Y. Bao, et al., “Comprehensive Genomic Analysis Reveals Extensive Diversity of Type I and Type Iv Secretion Systems in Klebsiella Pneumoniae,” Current Microbiology 80, no. 8 (2023): 270.

[346] D. L. Wannigama, C. Hurst, P. N. Monk, et al., “Tesg Expression as a Potential Clinical Biomarker for Chronic Pseudomonas Aeruginosa Pulmonary Biofilm Infections,” BMC Medicine [Electronic Resource] 23, no. 1 (2025): 191.

[347] D. C. Bui, T. Luo, and J. W. McBride, “Type 1 Secretion System and Effectors in Rickettsiales,” Frontiers in Cellular and Infection Microbiology 13 (2023): 1175688.

[348] E. Tang, A. C. Beltran, S. Mahendradeva, A. A. Badani, and D. J. Little, “Serine Phosphorylation of Cest by the Type Iii Secretion System Effectors Nleh1 and Nleh2 Regulates Antagonization of Csra in Enteropathogenic Escherichia Coli,” Infection and Immunity (2026): e0002726.

[349] J. E. Soto, T. Wang, J. E. Galán, and M. Lara-Tejero, “Interplay between Spao Variants Shapes the Architecture of the Salmonella Type Iii Secretion Sorting Platform,” MBio (2026): e0015526.

[350] F. J. Garcia-Rodriguez, P. Martinez-Oca, C. Buchrieser, and P. Escoll, “Complex I Preserves Mitochondrial Polarization during Infection of Human Macrophages by Secretion-Competent Bacteria,” Infection and Immunity (2026): e0049525.

[351] S. Guo, R. Puri, H. Seth, et al., “Development of a Novel Shigella Quadrivalent Conjugate Vaccine Using Shigella O-Polysaccharide and Ipab Carrier Protein,” Vaccines (Basel) 14, no. 2 (2026): 134.

[352] Y. Chen, B. Wu, L. Yang, et al., “The Small Non-Coding Rna Srna102 Regulates Pseudomonas Aeruginosa Virulence and Host Immunity by Targeting the T3ss Component Pcrg,” Frontiers in Cellular and Infection Microbiology 16 (2026): 1675468.

[353] Y. An, Y. Lee, Y. Jin, W. Wu, and U. H. Ha, “The Putative Rna Methyltransferase Modulates T3ss Expression and Host Nf-Κb Activation via T6ss-Mediated Translocation in Pseudomonas Aeruginosa,” International Journal of Molecular Sciences 27, no. 2 (2026): 818.

[354] X. Huang, X. Dong, C. Li, et al., “Xopa: A Novel Type Iii Secretion System Effector in Xenorhabdus That Modulates Host Cell Responses through Apoptosis, Autophagy, and Immune Evasion,” Microbiology Spectrum (2026): e0387125.

[355] A. L. de Oliveira, J. Ienes-Lima, N. L. Barbieri, et al., “The Type 6 Secretion System (T6ss) Plays a Role in the Pathogenesis of Strain Nmec15,” Microbial Pathogenesis 212 (2026): 108282.

[356] F. F. Li, J. J. Li, Y. Zhang, Z. Y. Wu, and Y. H. Xu, “Analysis of the Type Vi Secretion System and Microbiological Characteristics of Hypervirulent Klebsiella Pneumoniae Causing Urinary Tract Infections,” Journal of Infection in Developing Countries 20, no. 1 (2026): 70–78.

[357] J. Liu, J. Liu, C. Feng, and Q. Zou, “Divergent Roles of Hcp Genes in Salmonella Typhimurium T6ss Shape Gut Microbiota Dysbiosis during Infection,” Microbiology Spectrum (2026): e0222525.

[358] X. Wang, P. Yao, L. Liu, and Y. Zhang, “Functional Divergence and Regulatory Network of the Type Vi Secretion System in Vibrio Parahaemolyticus,” Journal of Bacteriology 208, no. 1 (2026): e0037825.

[359] R. Kofol, M. Pirs, T. Kotar, et al., “Genetic Diversity of Campylobacter Concisus Isolates from Slovenian Patients with Infectious Diarrhoea,” Microorganisms 14, no. 1 (2025): 87.

[360] N. C. Drebes Dörr, B. B. Ribeiro, A. H. B. Solano, et al., “Type Vi-Secretion System-Mediated Competition and Virulence in Clinical and Environmental Stenotrophomonas Maltophilia,” Microbiology Spectrum (2026): e0341125.

[361] J. Jie, S. Gu, D. Li, M. Zhang, Z. Q. Luo, and L. Song, “The Type Vi Secretion System of Acinetobacter: Mechanisms, Biology and Therapeutic Potential,” Communications Biology 9, no. 1 (2026): 327.

[362] L. Gao, T. Tian, T. Xiong, et al., “Type Vii Secretion System Extracellular Protein B Targets Sting to Evade Host Anti-Staphylococcus Aureus Immunity,” Proceedings of the National Academy of Sciences of the United States of America 121, no. 22 (2024): e2402764121.

[363] V. Stetsenko, D. P. Gail, S. M. Reba, et al., “Human Cd4+ T Cells Recognize Mycobacterium Tuberculosis-Infected Macrophages amid Broader Responses,” Journal of Experimental Medicine 222, no. 12 (2025): e20250460.

[364] A. Kengmo Tchoupa, K. E. Watkins, R. A. Jones, et al., “The Type Vii Secretion System Protects Staphylococcus Aureus against Antimicrobial Host Fatty Acids,” Scientific Reports 10, no. 1 (2020): 14838.

[365] C. Luo, X. Hao, X. Wang, et al., “Type Vii Secretion System Deploys an Active Iron Uptake Pathway to Enhance Bacterial Fitness and Counteract Host Nutritional Immunity,” MBio 16, no. 11 (2025): e0241925.

[366] Y. Schindler, G. Rahav, I. Nissan, et al., “Type Vii Secretion System and Its Effect on Group B Streptococcus Virulence in Isolates Obtained from Newborns with Early Onset Disease and Colonized Pregnant Women,” Frontiers in Cellular and Infection Microbiology 13 (2023): 1168530.

[367] B. L. Spencer, A. M. Job, C. M. Robertson, et al., “Heterogeneity of the Group B Streptococcal Type Vii Secretion System and Influence on Colonization of the Female Genital Tract,” BioRxiv (2023): 258–275.

[368] W. K. Teh, Y. Ding, F. Gubellini, et al., “Characterization of Tele, a T7ss Lxg Effector Exhibiting a Conserved C-Terminal Glycine Zipper Motif Required for Toxicity,” Microbiology Spectrum 11, no. 4 (2023): e0148123.

[369] H. Jiao, X. Li, Y. Li, et al., “Localized, Highly Efficient Secretion of Signaling Proteins by Migrasomes,” Cell Research 34, no. 8 (2024): 572–585.

[370] H. Liang, X. Ma, Y. Zhang, et al., “The Formation of Migrasomes Is Initiated by the Assembly of Sphingomyelin Synthase 2 Foci at the Leading Edge of Migrating Cells,” Nature Cell Biology 25, no. 8 (2023): 1173–1184.

[371] P. Sun, Y. Li, W. Yu, et al., “Low-Intensity Pulsed Ultrasound Improves Myocardial Ischaemia‒Reperfusion Injury via Migrasome-Mediated Mitocytosis,” Clinical and Translational Medicine 14, no. 7 (2024): e1749.

[372] Z. Zhai, B. Liu, and L. I. Yu, “The Roles of Migrasome in Development,” Cell Insight 3, no. 1 (2024): 100142.

[373] D. Wu, Y. Xu, T. Ding, Y. Zu, C. Yang, and L. Yu, “Pairing of Integrins with Ecm Proteins Determines Migrasome Formation,” Cell Research 27, no. 11 (2017): 1397–1400.

[374] R. Dharan, Y. Huang, S. K. Cheppali, et al., “Tetraspanin 4 Stabilizes Membrane Swellings and Facilitates Their Maturation into Migrasomes,” Nature Communications 14, no. 1 (2023): 1037.

[375] Y. Han and L. Yu, “Calcium Ions Promote Migrasome Formation via Synaptotagmin-1,” Journal of Cell Biology 223, no. 8 (2024): e202402060.

[376] Y. Li, Y. Wen, Y. Li, et al., “Rab10-Cav1 Mediated Intraluminal Vesicle Transport to Migrasomes,” Proceedings of the National Academy of Sciences of the United States of America 121, no. 30 (2024): e2319267121.

[377] Z. Huang, M. Wang, Y. Chen, et al., “Glioblastoma-Derived Migrasomes Promote Migration and Invasion by Releasing Pak4 and Lama4,” Communications Biology 8, no. 1 (2025): 91.

[378] Z. Li, T. K. Hailemariam, H. Zhou, et al., “Inhibition of Sphingomyelin Synthase (Sms) Affects Intracellular Sphingomyelin Accumulation and Plasma Membrane Lipid Organization,” Biochimica Et Biophysica Acta 1771, no. 9 (2007): 1186–1194.

[379] C. Zhang, T. Li, S. Yin, et al., “Monocytes Deposit Migrasomes to Promote Embryonic Angiogenesis,” Nature Cell Biology 24, no. 12 (2022): 1726–1738.

[380] D. Jiang, Z. Jiang, D. Lu, et al., “Migrasomes Provide Regional Cues for Organ Morphogenesis during Zebrafish Gastrulation,” Nature Cell Biology 21, no. 8 (2019): 966–977.

[381] M. Zhu, Q. Zou, R. Huang, et al., “Lateral Transfer of Mrna and Protein by Migrasomes Modifies the Recipient Cells,” Cell Research 31, no. 2 (2021): 237–240.

[382] C. S. Jensen, S. Watanabe, J. I. Stas, et al., “Trafficking of Kv2.1 Channels to the Axon Initial Segment by a Novel Nonconventional Secretory Pathway,” Journal of Neuroscience 37, no. 48 (2017): 11523–11536.

[383] A. B. Bowen, A. M. Bourke, B. G. Hiester, C. Hanus, and M. J. Kennedy, “Golgi-Independent Secretory Trafficking through Recycling Endosomes in Neuronal Dendrites and Spines,” Elife 6 (2017): e27362.

[384] L. A. Earl and L. G. Baum, “Cd45 Glycosylation Controls T-Cell Life and Death,” Immunology and Cell Biology 86, no. 7 (2008): 608–615.

[385] T. A. Baldwin and H. L. Ostergaard, “The Protein-Tyrosine Phosphatase Cd45 Reaches the Cell Surface via Golgi-Dependent and -Independent Pathways,” Journal of Biological Chemistry 277, no. 52 (2002): 50333–50340.

[386] E. I. Deryugina, B. I. Ratnikov, Q. Yu, P. C. Baciu, D. V. Rozanov, and A. Y. Strongin, “Prointegrin Maturation Follows Rapid Trafficking and Processing of Mt1-Mmp in Furin-Negative Colon Carcinoma Lovo Cells,” Traffic 5, no. 8 (2004): 627–641.

[387] J. Meldolesi, “Cancer Stem Cells and Their Vesicles, Together with Other Stem and Non-Stem Cells, Govern Critical Cancer Processes: Perspectives for Medical Development,” International Journal of Molecular Sciences 23, no. 2 (2022): 625.

[388] Z. Li, W. J. Fu, X. Q. Chen, et al., “Autophagy-Based Unconventional Secretion of Hmgb1 in Glioblastoma Promotes Chemosensitivity to Temozolomide through Macrophage M1-Like Polarization,” Journal of Experimental & Clinical Cancer Research 41, no. 1 (2022): 74.

[389] C. Zhang, H.-M. Ma, S. Wu, et al., “Secreted Pten Binds Plxdc2 on Macrophages to Drive Antitumor Immunity and Tumor Suppression,” Developmental Cell 59, no. 23 (2024): 3072–3088.e8.

[390] G. Minakaki, S. Menges, A. Kittel, et al., “Autophagy Inhibition Promotes Snca/Alpha-Synuclein Release and Transfer via Extracellular Vesicles with a Hybrid Autophagosome-Exosome-Like Phenotype,” Autophagy 14, no. 1 (2018): 98–119.

[391] P. Nilsson, K. Loganathan, M. Sekiguchi, et al., “Aβ Secretion and Plaque Formation Depend on Autophagy,” Cell Reports 5, no. 1 (2013): 61–69.

[392] L. Rodriguez, N. V. Mohamed, A. Desjardins, R. Lippé, E. A. Fon, and N. Leclerc, “Rab7a Regulates Tau Secretion,” Journal of Neurochemistry 141, no. 4 (2017): 592–605.

[393] W. S. Lee, D. C. Tan, Y. Deng, et al., “Syntaxins 6 and 8 Facilitate Tau into Secretory Pathways,” Biochemical Journal 478, no. 7 (2021): 1471–1484.

[394] C. Gomes, S. Keller, P. Altevogt, and J. Costa, “Evidence for Secretion of Cu,Zn Superoxide Dismutase via Exosomes from a Cell Model of Amyotrophic Lateral Sclerosis,” Neuroscience Letters 428, no. 1 (2007): 43–46.

[395] C. Münch, J. O'Brien, and A. Bertolotti, “Prion-Like Propagation of Mutant Superoxide Dismutase-1 Misfolding in Neuronal Cells,” Proceedings of the National Academy of Sciences of the United States of America 108, no. 9 (2011): 3548–3553.

[396] L. I. Grad, J. J. Yerbury, B. J. Turner, et al., “Intercellular Propagated Misfolding of Wild-Type Cu/Zn Superoxide Dismutase Occurs via Exosome-Dependent and -Independent Mechanisms,” Proceedings of the National Academy of Sciences of the United States of America 111, no. 9 (2014): 3620–3625.

[397] A.-J. Hutchings, B. Hambrecht, A. Veh, et al., “Plekhg5 Controls the Unconventional Secretion of Sod1 by Presynaptic Secretory Autophagy,” Nature Communications 15, no. 1 (2024): 8622.

[398] E. Ahat, S. Bui, J. Zhang, et al., “Grasp55 Regulates the Unconventional Secretion and Aggregation of Mutant Huntingtin,” Journal of Biological Chemistry 298, no. 8 (2022): 102219.

[399] Z. Wang, H. Zhou, H. Zheng, et al., “Autophagy-Based Unconventional Secretion of Hmgb1 by Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation,” Autophagy 17, no. 2 (2021): 529–552.

[400] S. Caielli, P. Balasubramanian, J. Rodriguez-Alcazar, et al., “Type I Ifn Drives Unconventional Il-1β Secretion in Lupus Monocytes,” Immunity 57, no. 11 (2024): 2497–2513.e12.

[401] C. W. Keller, I. E. Adamopoulos, and J. D. Lünemann, “Autophagy Pathways in Autoimmune Diseases,” Journal of Autoimmunity 136 (2023): 103030.

[402] L. Liu, L. Zhang, X. Hao, et al., “Coronavirus Envelope Protein Activates Tmed10-Mediated Unconventional Secretion of Inflammatory Factors,” Nature Communications 15, no. 1 (2024): 8708.

[403] M. Jiao, C. Wang, X. Tang, et al., “Active Secretion of Il-33 from Astrocytes Is Dependent on Tmed10 and Promotes Central Nervous System Homeostasis,” Brain, Behavior, and Immunity 119 (2024): 539–553.

[404] Y. Wang, M. Huang, X. Mu, et al., “Tmed10-Mediated Unconventional Secretion of Il-33 Regulates Intestinal Epithelium Differentiation and Homeostasis,” Cell Research 34, no. 3 (2024): 258–261.

[405] Q. Huang, S. Wang, Z. Liu, L. Rao, K. Cheng, and X. Mao, “Engineering Exosomes for Targeted Neurodegenerative Therapy: Innovations in Biogenesis, Drug Loading, and Clinical Translation,” Theranostics 16, no. 1 (2026): 545–579.

[406] J. Cao, G. Lv, and F. Wei, “Engineering Exosomes to Reshape the Immune Microenvironment in Breast Cancer: Molecular Insights and Therapeutic Opportunities,” Clinical and Translational Medicine 14, no. 4 (2024): e1645.

[407] J. Gou, L. Zhang, G. Wang, Z. Li, Q. Yin, and Y. Pan, “Inhalable Exosomes in Respiratory Therapies with the Transformative Potential,” International Journal of Nanomedicine 20 (2025): 14219–14252.

[408] J. Li, S. Sun, D. Zhu, et al., “Inhalable Stem Cell Exosomes Promote Heart Repair after Myocardial Infarction,” Circulation 150, no. 9 (2024): 710–723.

[409] H. Cao, Z. Li, J. Ye, et al., “Emerging Roles of Exosomes in the Diagnosis and Treatment of Kidney Diseases,” Frontiers in Pharmacology 16 (2025): 1525314.

[410] P. P. An, Y. Li, J. H. Yu, B. Zhou, and J. M. Yue, “Harperoids a-F, Complex Polyprenylated Acylphloroglucinols from Harrisonia Perforata That Reverse Multidrug Resistance by Targeting Abc Transporter Function,” Journal of Organic Chemistry 91, no. 7 (2026): 2915–2927.

[411] Q. Jiang, M. Jiang, Y. Lv, X. Zhang, S. Wang, and J. Zhao, “Disulfiram as an Anti-Inflammatory Agent: Mechanisms, Nano-Delivery Strategies, and Applications in Non-Oncologic Diseases,” RSC Advances 15, no. 43 (2025): 36344–36364.

[412] X. Chen, J. K. Kordich, E. T. Williams, et al., “Parkinson's Disease-Linked D620n Vps35 Knockin Mice Manifest Tau Neuropathology and Dopaminergic Neurodegeneration,” Proceedings of the National Academy of Sciences of the United States of America 116, no. 12 (2019): 5765–5774.

[413] C. D. Gonzalez, R. Resnik, and M. I. Vaccaro, “Secretory Autophagy and Its Relevance in Metabolic and Degenerative Disease,” Frontiers in Endocrinology (Lausanne) 11 (2020): 266.

[414] H. Dong, J. Jiang, K. Ni, et al., “Trim16: A Context-Dependent E3 Ligase in Autophagy, Oxidative Stress, and Immune Regulation - from Cancer and Systemic Disease,” Frontiers in Oncology 16 (2026): 1743345.

[415] J. M. T. Hyttinen, M. Niittykoski, and K. Kaarniranta, “The Role of Secretory Autophagy and Exosomes in the Accumulation of Drusen during the Development of Age-Related Macular Degeneration (Amd),” Ageing Research Reviews 110 (2025): 102796.

[416] Y. Liang, L. Duan, J. Lu, and J. Xia, “Engineering Exosomes for Targeted Drug Delivery,” Theranostics 11, no. 7 (2021): 3183–3195.

[417] M. M. I. Abdalla, P. Bhatnagar, M. H. B. Zulkaflee, A. M. S. Mohammed Irfan, and N. Eid, “Intermittent Fasting Enhances Cancer Therapy via Autophagy-Dependent and Independent Mechanisms: Evidence and Implications,” World Journal of Clinical Oncology 17, no. 2 (2026): 115289.

[418] S. P. Jochems, D. M. Ferreira, and H. H. Smits, “Microbiota and Compartment Matter in the Covid-19 Response,” Nature Immunology 22, no. 11 (2021): 1350–1352.

[419] M. Denus, A. Filaquier, W. Fargues, et al., “A Sensitive and Versatile Cell-Based Assay Combines Luminescence and Trapping Approaches to Monitor Unconventional Protein Secretion,” Traffic 26, no. 4–6 (2025): e70009.

[420] J. Schira-Heinen, L. Grube, D. M. Waldera-Lupa, et al., “Pitfalls and Opportunities in the Characterization of Unconventionally Secreted Proteins by Secretome Analysis,” Biochimica et Biophysica Acta - Proteins and Proteomics 1867, no. 12 (2019): 140237.

RIGHTS & PERMISSIONS

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.